Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023709	fs-gh	ug/l (ug/l)	1448	3755	1.76%
3023709	fs-gh	ug/L (ug/l)	118	434	0.00%
3023709	s-gh	ug/l (ug/l)	118	218	0.00%
3023709	s-gh	— (—)	59	83	100.00%	Distribution not available
3023709	fs-gh	ug/l______ (ug/l)	48	68	0.00%
3023709	fs-gh	µg/l (ug/l)	14	14	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

519

255

10.36

312.31

3.1

1.4

1.23

0.97

ug/l

1.20

482

247

Exclusions for E4_PCOS_CONSORTIUM

909

460

12.57

307.65

3.3

1.7

1.10

1.38

ug/l

1.66

857

443

Benign neoplasm of other and unspecified endocrine glands

518

126

44.98

307.65

3.9

1.5

0.99

1.01

ug/l

0.05

506

118

Used for control exclusion in common control thyroid runs

705

427

8.39

307.65

3.1

1.9

1.12

1.29

ug/l

0.69

659

414

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

877

290

31.78

307.65

3.6

1.7

1.01

1.36

ug/l

1.92

833

275

Exclusions for E4_PCOS_BROAD

966

159

68.52

307.65

3.5

2.3

1.09

1.49

ug/l

1.60

915

151

Disorders of other endocrine glands

1001

371

27.63

307.65

3.5

1.4

1.18

1.32

ug/l

0.51

944

354

Panhypopituitarism

138

107.96

267.34

3.0

2.1

0.74

1.00

ug/l

0.28

131

Short stature, not elsewhere classified

148

74.35

255.34

6.3

3.0

1.99

3.73

ug/l

1.24

148

Hypothyroidism, other/unspecified

529

731

4.79

199.19

2.5

2.3

1.04

1.15

ug/l

0.44

498

702

Hypothyreosis and Thyroxine purchase for inclusion criteria

538

796

4.46

186.34

2.5

2.3

1.03

1.15

ug/l

0.49

507

766

Disorders of the thyroid gland

536

786

4.45

184.71

2.4

2.3

1.04

1.10

ug/l

0.21

505

752

Benign neoplasms

498

742

3.67

125.96

3.1

2.0

1.02

1.13

ug/l

0.51

470

691

Neoplasms

407

632

3.40

91.26

3.0

2.4

1.07

1.25

ug/l

0.90

384

590

Sleep apnoea

411

866

3.00

81.42

2.4

2.5

0.95

1.13

ug/l

0.71

375

834

Sleep apnoea, including avohilmo

421

909

2.81

73.48

2.4

2.5

0.95

1.14

ug/l

0.96

386

876

Medical observation and evaluation for suspected diseases and conditions

302

440

3.52

70.84

2.0

2.6

0.96

1.14

ug/l

0.66

280

416

Hypothyroidism, strict autoimmune

204

329

4.08

64.19

1.3

1.5

1.22

1.07

ug/l

0.45

187

321

General symptoms and signs

438

851

2.59

61.84

2.1

2.8

1.19

0.99

ug/l

1.02

410

806

Headache

299

789

2.94

60.84

2.5

2.8

1.11

1.00

ug/l

0.29

286

752

Episodal and paroxysmal disorders

444

899

2.51

59.53

2.4

2.9

1.09

1.29

ug/l

1.09

410

871

Sleep disorders (combined)

416

866

2.52

56.51

2.3

2.7

1.06

1.17

ug/l

0.43

387

836

First line medication for Crohn's disease

456

1041

2.36

54.91

2.4

2.7

1.04

1.17

ug/l

0.61

425

991

Other disorders of fluid, electrolyte and acid-base balance

144

321

4.25

54.00

2.5

1.06

1.08

ug/l

0.04

139

307

Malaise and fatigue

218

526

3.28

53.49

1.8

3.1

1.36

1.03

ug/l

1.29

206

507

Mood disorders, excluding more controls

374

888

2.48

51.34

1.9

2.6

0.99

1.04

ug/l

0.18

347

849

Depression

389

1118

2.33

48.47

2.0

2.6

0.99

1.10

ug/l

0.49

362

1064

Neurological diseases

347

689

2.54

47.42

2.5

3.1

1.14

1.30

ug/l

0.61

321

665

Mood [affective] disorders

402

1139

2.27

46.44

1.9

2.6

0.98

1.10

ug/l

0.52

373

1085

Mood disorders

403

1141

2.26

46.43

1.9

2.6

0.98

1.09

ug/l

0.49

374

1087

Other antidepressants

355

762

2.38

43.06

1.7

2.6

0.89

1.07

ug/l

0.82

329

725

Abnormalities of breathing

368

922

2.29

42.26

2.2

3.0

1.18

1.16

ug/l

0.04

347

876

Recurrent or chronic depression

168

356

3.29

40.06

1.5

2.6

0.77

1.08

ug/l

1.05

157

338

Any reimbursement code in KELA

250

458

2.75

39.70

2.8

2.4

1.15

ug/l

0.00

233

433

Anxiety disorders, excluding more controls

319

875

2.34

39.54

2.2

2.7

0.99

1.07

ug/l

0.30

305

836

Visual disturbances and blindness

221

839

2.64

39.44

2.5

2.7

0.99

1.21

ug/l

1.11

216

798

Visual disturbances

209

781

2.69

38.61

2.4

2.6

0.99

1.23

ug/l

1.19

204

741

Short stature starting before birth

15.15

37.57

6.4

6.2

2.30

2.55

ug/l

0.15

Benign neoplasm of meninges

111

5.93

36.45

2.7

2.3

0.65

1.21

ug/l

1.89

104

Fever of other and unknown origin

211

698

2.63

36.15

2.1

3.0

1.10

1.02

ug/l

0.24

199

668

Depression or dysthymia

228

472

2.65

34.92

2.3

2.8

0.87

1.06

ug/l

0.71

218

454

Hypertension, essential

280

669

2.37

34.80

2.4

2.2

1.14

0.92

ug/l

0.91

260

629

Selective serotonin reuptake inhibitors

340

806

2.20

34.73

2.0

2.8

1.12

1.09

ug/l

0.08

318

769

Benign neoplasm: Cerebral meninges

104

5.94

34.28

2.7

2.1

0.69

1.25

ug/l

1.73

Neurotic, stress-related and somatoform disorders

351

1165

2.08

33.66

2.3

2.6

1.05

1.09

ug/l

0.12

336

1099

Anxiety disorders

352

1168

2.07

33.39

2.2

2.6

1.05

1.09

ug/l

0.13

337

1102

Persons encountering health services in other circumstances

183

692

2.63

32.35

2.0

2.9

0.90

1.16

ug/l

1.10

171

662

Metabolic disorders

342

983

2.09

32.21

3.1

2.5

1.21

1.11

ug/l

0.26

323

929

Other nutritional deficiencies

270

1120

2.21

31.99

2.0

2.6

0.82

1.21

ug/l

3.13

248

1077

Hypertension

295

751

2.22

31.67

2.5

1.26

1.03

ug/l

0.95

277

706

Hypertensive diseases (excluding secondary)

229

539

2.48

31.57

2.8

1.26

1.09

ug/l

0.57

212

508

Hypertensive diseases

295

753

2.22

31.49

2.5

1.26

1.03

ug/l

0.95

277

708

Benzodiazepine use

356

1200

2.01

30.91

1.9

2.5

1.07

1.06

ug/l

0.01

335

1135

Neurological diseases, wide definition

156

252

3.12

30.85

2.6

3.7

1.07

1.38

ug/l

1.12

144

246

Benign thyroid growths and nodules

100

264

3.53

29.17

2.7

2.0

1.11

1.04

ug/l

0.14

251

Codeine

324

855

2.05

28.35

2.2

2.3

1.00

1.04

ug/l

0.11

307

807

Any gastric operation

293

684

2.15

28.35

2.7

1.35

1.08

ug/l

1.26

273

649

GASTRO-related operations

293

684

2.15

28.35

2.7

1.35

1.08

ug/l

1.26

273

649

Other headache syndromes

149

551

2.70

28.04

2.4

2.5

0.93

1.27

ug/l

1.34

142

536

Other special examinations and investigations of persons without complaint or reported diagnosis

213

440

2.46

27.74

2.4

2.6

1.16

1.14

ug/l

0.04

197

416

Obesity and other hyperalimentation

248

1090

2.15

27.57

2.0

2.6

0.68

1.21

ug/l

6.75

227

1046

Obesity

246

1086

2.14

27.16

2.0

2.6

0.68

1.21

ug/l

6.60

225

1042

Oedema, not elsewhere classified

109

339

3.15

26.92

1.9

2.8

1.03

1.08

ug/l

0.08

103

329

Symptoms and signs involving the circulatory and respiratory systems

359

924

1.95

26.87

2.2

3.0

1.26

1.16

ug/l

0.32

343

878

Anxiety (asthma-related co-morbidities)

247

871

2.16

26.85

2.2

2.7

1.10

1.08

ug/l

0.06

238

826

Brain meningioma

7.34

26.75

2.4

1.9

0.73

1.08

ug/l

0.66

Codeine or tramadol medication

368

1045

1.92

26.73

2.1

2.3

1.01

1.06

ug/l

0.15

348

984

Intracranial trauma

205

588

2.36

26.65

2.3

3.3

1.12

1.30

ug/l

0.54

196

567

Brain meningioma, including Hilmo

7.20

26.32

2.4

1.9

0.73

1.06

ug/l

0.61

General examination and investigation of persons without complaint and reported diagnosis

205

440

2.43

26.20

2.1

2.6

1.35

1.14

ug/l

0.39

194

416

Persons encountering health services in other circumstances, wide

398

1103

1.86

26.02

2.3

2.8

1.19

1.11

ug/l

0.27

370

1054

Obesity related asthma

143

549

2.62

25.26

2.2

2.7

0.92

1.06

ug/l

0.38

130

522

Any mental disorder

356

934

1.91

25.21

2.4

2.7

1.27

1.11

ug/l

0.65

335

895

Implicit viral Sepsis, including avohilmo

119

417

2.86

24.94

2.2

2.9

1.38

1.13

ug/l

0.59

110

397

All anxiety disorders

255

960

2.07

24.87

2.3

2.6

1.13

1.07

ug/l

0.15

246

899

Obesity due to excess calories

192

853

2.26

24.62

1.9

2.7

0.69

1.25

ug/l

5.77

177

819

Persons with potential health hazards related to communicable diseases

192

846

2.26

24.54

2.6

2.9

1.21

1.30

ug/l

0.29

186

800

Opioids

328

875

1.94

24.41

2.3

1.05

1.04

ug/l

0.05

309

827

Exposure to unspecified factor

362

1359

1.81

23.54

2.3

2.8

1.17

1.16

ug/l

0.01

343

1292

Other soft tissue disorders, not elsewhere classified

338

1034

1.86

22.93

2.2

2.9

1.13

1.19

ug/l

0.20

317

987

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

192

848

2.19

22.71

2.3

2.5

1.32

1.08

ug/l

0.39

186

801

Other disorders of lacrimal gland

133

526

2.54

22.17

2.2

2.5

1.32

1.14

ug/l

0.38

126

497

Concussion

171

578

2.30

21.78

2.5

3.3

0.97

1.31

ug/l

1.53

163

558

Gastro-oesophageal reflux disease

232

970

2.02

21.78

2.4

2.7

1.09

1.07

ug/l

0.06

216

930

Psychiatric diseases

306

806

1.91

21.54

2.5

2.8

1.29

1.10

ug/l

0.71

288

773

Pain in joint

203

574

2.18

21.51

2.3

3.0

1.05

1.10

ug/l

0.14

186

541

Antihypertensive medication - note that there are other indications

258

671

2.01

21.46

2.4

3.1

1.44

1.16

ug/l

1.00

241

637

Parasetamol

246

606

2.06

21.42

2.3

2.4

0.96

ug/l

0.02

225

572

Behavioural syndromes associated with physiological disturbances and physical factors

325

1212

1.82

21.28

2.2

2.6

1.12

1.10

ug/l

0.06

305

1149

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

344

1237

1.79

21.06

2.6

2.7

1.14

ug/l

0.02

329

1172

Polycystic ovarian syndrome, consortium definition

234

655

2.05

21.04

2.3

1.17

1.25

ug/l

0.22

224

634

Mouth breathing

162

718

2.26

20.91

2.6

3.2

1.13

1.30

ug/l

0.40

148

686

Pain in limb

294

1000

1.87

20.84

2.1

2.9

1.07

1.19

ug/l

0.54

278

958

Other anxiety disorders

193

775

2.13

20.73

2.1

2.5

1.12

1.09

ug/l

0.07

187

722

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

110

404

2.70

20.72

1.2

2.5

1.07

1.09

ug/l

0.04

103

382

Contact with and exposure to communicable diseases

159

701

2.27

20.64

2.5

3.0

1.25

1.32

ug/l

0.17

154

665

Nausea and vomiting

115

432

2.61

20.18

2.6

3.4

1.81

1.28

ug/l

1.22

109

414

Gastrointestinal diseases

224

542

2.08

20.00

3.0

2.7

1.31

1.14

ug/l

0.47

207

518

Asthma

255

672

1.96

19.70

2.4

2.9

1.09

1.06

ug/l

0.09

240

644

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

126

237

2.67

19.43

2.4

3.1

1.20

0.87

ug/l

0.89

115

220

Other diseases of intestines

365

1180

1.73

19.31

2.9

2.6

1.29

1.16

ug/l

0.49

343

1120

Asthma, excluding more controls

250

656

1.96

19.29

2.4

2.9

1.10

1.05

ug/l

0.14

235

628

Personality disorders, excluding more controls

102

379

2.70

19.25

1.5

2.5

1.19

1.01

ug/l

0.39

353

Disorders of lacrimal system

145

629

2.27

18.99

2.1

2.6

1.25

1.12

ug/l

0.30

138

600

Cardiovascular diseases (excluding rheumatic etc)

266

808

1.89

18.93

2.7

3.0

1.33

1.21

ug/l

0.37

247

768

Intestinal infectious diseases

321

1367

1.75

18.91

2.5

2.7

1.24

1.15

ug/l

0.30

307

1295

Implicit Sepsis

241

930

1.91

18.89

2.1

2.7

1.41

1.04

ug/l

1.65

229

883

Symptoms and signs involving the nervous and musculoskeletal systems

197

983

2.01

18.82

2.1

2.8

1.50

1.21

ug/l

0.81

187

939

Syncope and collapse

129

449

2.40

18.56

1.9

2.9

1.08

0.97

ug/l

0.32

122

430

Tramadol

243

762

1.92

18.46

1.9

2.3

0.95

1.05

ug/l

0.33

235

719

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

324

1261

1.73

18.22

2.4

2.7

1.08

1.19

ug/l

0.45

304

1207

Asthma (mode)

247

677

1.92

18.13

2.4

2.9

1.09

1.06

ug/l

0.08

233

649

Implicit Sepsis, including avohilmo

263

1027

1.83

17.99

2.1

2.7

1.35

1.03

ug/l

1.42

248

975

ILD medications: prednisolone, methylprednisolone, prednisone

357

1172

1.70

17.79

2.0

2.8

1.14

1.11

ug/l

0.10

334

1118

Persons encountering health services for other counselling and medical advice, not elsewhere classified

353

1102

1.70

17.73

2.4

2.8

1.28

1.11

ug/l

0.52

328

1053

Asthma, unspecified (mode)

178

618

2.08

17.65

2.2

2.9

0.99

1.09

ug/l

0.27

172

597

Diseases of oesophagus, stomach and duodenum

343

1194

1.70

17.44

2.3

2.6

1.33

1.06

ug/l

1.05

322

1133

Asthma (only as main-diagnosis), excluding more controls

229

656

1.93

17.41

2.3

2.9

1.12

1.05

ug/l

0.18

214

628

Diarrhoea and gastroenteritis of presumed infectious origin

250

1231

1.82

17.35

2.5

2.7

1.18

ug/l

0.02

239

1160

Irregular menses

169

606

2.10

17.27

2.3

1.14

1.23

ug/l

0.25

161

588

Spondylosis

157

571

2.15

17.26

1.8

2.4

0.95

1.06

ug/l

0.20

147

548

Sleep disorders

292

1147

1.76

17.25

2.1

2.5

1.10

1.09

ug/l

0.02

274

1084

Pain in throat and chest

267

869

1.82

17.25

2.0

2.9

1.17

1.08

ug/l

0.30

254

824

Asthma, unspecified (mode), excluding more controls

175

604

2.08

17.22

2.2

2.9

1.00

1.08

ug/l

0.21

169

582

Asthma (only as main-diagnosis)

230

672

1.92

17.11

2.3

2.9

1.12

1.06

ug/l

0.15

215

644

Low back pain

249

918

1.83

16.93

2.1

2.6

1.04

1.11

ug/l

0.22

234

871

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

194

864

1.96

16.88

2.3

2.7

0.98

1.10

ug/l

0.41

185

827

Oral corticosteroids

337

1170

1.69

16.86

1.9

2.6

1.10

1.07

ug/l

0.08

322

1104

Cardiovascular diseases

253

728

1.85

16.67

2.7

3.0

1.46

1.23

ug/l

0.72

235

693

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

293

1147

1.73

16.30

2.2

2.7

1.32

1.09

ug/l

0.99

278

1086

Other functional intestinal disorders

156

683

2.08

16.20

2.8

1.23

1.30

ug/l

0.15

149

658

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

131

513

2.24

16.16

2.8

3.1

1.61

1.31

ug/l

0.69

125

484

Triptan medication for migraine, min. 3 purchases

204

800

1.91

16.07

1.9

2.5

0.99

1.22

ug/l

1.00

196

762

Hypothyroidism, strict autoimmune, 3 medication purchases required

209

737

1.91

16.06

1.3

2.3

1.18

1.16

ug/l

0.05

193

711

Abnormalities of heart beat

112

461

2.36

16.06

1.8

2.7

1.58

1.10

ug/l

0.68

105

439

Nerve, nerve root and plexus disorders

315

1117

1.70

16.05

2.4

2.3

0.96

1.10

ug/l

0.64

298

1053

Intestinal infectious diseases, including avohilmo, including avohilmo

361

1226

1.64

16.02

2.6

2.7

1.18

1.13

ug/l

0.17

345

1162

Glucagon-like peptide-1 (GLP-1) analogues

107

447

2.40

16.02

2.0

2.4

0.79

0.98

ug/l

0.77

427

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

107

447

2.40

16.02

2.0

2.4

0.79

0.98

ug/l

0.77

427

Complications of procedures, not elsewhere classified

249

1131

1.78

15.82

2.4

1.12

1.11

ug/l

0.04

240

1075

Symptoms and signs involving cognition, perception, emotional state and behaviour

300

1182

1.70

15.72

2.2

2.5

1.23

1.08

ug/l

0.64

284

1124

Dyspnoea

275

1153

1.72

15.45

2.0

2.7

1.04

1.15

ug/l

0.49

258

1105

Bipolar affective disorders

287

2.73

15.20

1.4

2.6

1.20

1.08

ug/l

0.17

268

Spondylopathies

222

712

1.85

15.05

2.0

2.6

0.92

1.12

ug/l

0.59

206

682

Abdominal and pelvic pain

316

945

1.68

15.02

2.2

2.9

1.13

1.10

ug/l

0.08

297

897

Persons encountering health services for examination and investigation

177

440

2.02

14.91

2.4

2.6

1.09

1.14

ug/l

0.09

166

416

Dorsalgia

307

967

1.68

14.88

1.9

2.6

0.98

1.13

ug/l

0.75

287

918

Condition for Implicit Sepsis (Organ dysfunction codes)

265

1065

1.73

14.87

2.1

2.7

1.34

1.07

ug/l

1.06

251

1011

Soft tissue disorders

336

1048

1.64

14.77

2.6

2.9

1.15

1.19

ug/l

0.14

313

1001

Aplastic and other anaemias

126

531

2.18

14.77

2.2

2.8

1.25

1.13

ug/l

0.27

120

511

Other symptoms and signs involving the nervous and musculoskeletal systems

147

724

2.04

14.71

2.0

2.8

1.52

1.08

ug/l

1.22

142

690

Symptoms and signs involving the digestive system and abdomen

315

945

1.67

14.70

2.3

2.9

1.18

1.10

ug/l

0.24

297

897

Obesity, other/unspecified

122

560

2.19

14.69

2.0

2.5

0.69

1.25

ug/l

3.67

110

536

Type 2 diabetes, wide definition

214

733

1.84

14.67

2.4

1.08

0.96

ug/l

0.31

199

696

Insomnia

281

1160

1.69

14.56

2.1

2.4

1.10

1.09

ug/l

0.02

265

1094

Symptoms and signs involving the skin and subcutaneous tissue

228

1224

1.76

14.53

2.7

2.5

1.40

1.12

ug/l

0.82

219

1170

167

862

1.93

14.29

2.6

2.9

1.17

1.30

ug/l

0.30

158

819

Diseases of the ear and mastoid process

357

1116

1.61

14.22

2.3

2.7

1.08

1.13

ug/l

0.20

333

1058

Type 2 diabetes, definitions combined

278

954

1.70

14.20

2.4

2.3

0.89

1.01

ug/l

0.60

257

910

Migraine, single triptan purchase ok & required. ICD-code if available is included

256

1009

1.72

14.19

2.2

2.5

0.96

1.12

ug/l

0.79

236

956

Triptan medication for migraine, single purchase ok

256

1009

1.72

14.19

2.2

2.5

0.96

1.12

ug/l

0.79

236

956

Poisoning by medicine

382

2.42

14.04

1.3

2.5

1.13

1.01

ug/l

0.23

355

ILD medications

360

1222

1.59

14.02

2.1

2.9

1.20

1.13

ug/l

0.21

334

1167

Type 2 diabetes

291

1010

1.67

13.99

2.4

2.3

1.00

1.02

ug/l

0.05

267

957

Type 2 diabetes, definitions combined, including avohilmo

279

957

1.69

13.95

2.3

0.88

0.99

ug/l

0.51

256

913

Nontoxic goitre/thyroid nodule

353

2.47

13.94

2.7

2.1

1.16

1.10

ug/l

0.11

337

Pain (limb, back, neck, head abdominally)

224

621

1.81

13.75

2.5

3.1

1.21

1.19

ug/l

0.02

212

588

Implicit viral Sepsis

280

2.65

13.70

2.0

2.9

1.55

1.10

ug/l

0.84

264

Viral Sepsis

280

2.65

13.70

2.0

2.9

1.55

1.10

ug/l

0.84

264

Type 2 diabetes, strict (exclude DM1)

277

960

1.68

13.68

2.4

2.3

0.88

1.01

ug/l

0.61

256

916

Disorders of lipoprotein metabolism and other lipidaemias

215

726

1.80

13.66

2.6

2.3

1.07

0.96

ug/l

0.21

204

682

Acetic acid derivatives and related substances

143

2.83

13.57

1.8

2.3

1.22

0.93

ug/l

0.49

137

Autoimmune diseases

354

1133

1.59

13.56

2.0

2.9

1.31

1.08

ug/l

1.00

325

1084

Other anaemias

114

491

2.18

13.49

2.2

2.7

1.18

1.12

ug/l

0.13

108

474

Diseases of the eye and adnexa

272

805

1.70

13.40

2.5

2.7

1.27

1.17

ug/l

0.32

257

754

Dizziness and giddiness

210

923

1.77

13.26

2.2

2.6

1.22

1.05

ug/l

0.64

199

883

Implicit bacterial Sepsis, including avohilmo

125

496

2.10

13.21

1.9

2.7

1.51

1.05

ug/l

1.17

119

475

Abnormal weight loss

126

3.52

13.18

1.6

3.1

1.50

1.62

ug/l

0.11

118

Other and unspecified anaemias

112

487

2.16

13.07

2.2

2.7

1.21

1.13

ug/l

0.16

106

470

Complications of surgical and medical care, not elsewhere classified

293

1207

1.62

12.98

2.4

2.5

1.11

1.09

ug/l

0.07

281

1143

Disturbances of skin sensation

103

468

2.21

12.79

2.9

2.4

1.30

1.03

ug/l

0.61

442

Poisoning by drugs, medicaments and biological substances

431

2.26

12.72

1.4

2.5

1.14

1.02

ug/l

0.24

402

Other dorsopathies, not elsewhere classified

303

974

1.62

12.64

2.0

2.7

1.02

1.13

ug/l

0.48

283

925

Genitourinary diseases

211

591

1.79

12.64

2.7

3.3

1.18

1.14

ug/l

0.12

197

557

Primary adrenocortical insufficiency

18.00

12.62

1.2

2.2

1.06

1.18

ug/l

0.08

Nonorganic sleeping disorders, excluding more controls

310

2.49

12.60

2.4

2.8

0.93

1.05

ug/l

0.22

293

Asthma, hospital admissions , main diagnosis only

259

1377

1.64

12.55

2.5

2.7

1.16

1.18

ug/l

0.06

244

1314

Asthma, hospital admission 2, infections

192

1063

1.76

12.44

2.5

2.8

1.18

1.25

ug/l

0.14

182

1010

Asthma-related infections

192

1063

1.76

12.44

2.5

2.8

1.18

1.25

ug/l

0.14

182

1010

Continuous positive airway pressure

232

2.60

12.30

2.6

4.0

1.39

1.40

ug/l

0.01

227

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

127

629

2.00

12.20

3.4

3.0

1.60

1.36

ug/l

0.56

119

603

Autoimmune diseases excluding thyroid diseases

325

1122

1.57

12.18

2.5

2.9

1.31

1.06

ug/l

1.10

308

1073

Nontoxic multinodular goitre

138

3.27

12.13

2.7

1.6

1.34

1.10

ug/l

0.29

132

Dysphagia

292

2.51

12.12

2.5

2.7

1.03

1.07

ug/l

0.08

277

Asthma (diagnoses ohter than nonallergic)

273

1374

1.61

12.11

2.3

2.7

1.08

1.21

ug/l

0.43

259

1312

Inflammatory bowel disease treatment related agents

350

1263

1.54

12.02

2.1

2.7

1.22

1.10

ug/l

0.49

332

1197

Diseases of the musculoskeletal system and connective tissue

200

563

1.79

11.82

2.7

3.1

1.35

1.26

ug/l

0.20

183

540

Pain, not elsewhere classified

365

2.31

11.64

2.2

3.1

1.06

1.08

ug/l

0.04

349

Other specific joint derangements/joint disorders

241

906

1.66

11.62

2.1

2.5

1.04

1.10

ug/l

0.16

221

864

Bacterial Sepsis

126

525

1.99

11.54

2.1

2.8

1.52

1.03

ug/l

1.34

121

501

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

110

535

2.06

11.53

1.2

2.4

1.07

1.18

ug/l

0.27

103

505

Other symptoms and signs involving cognitive functions and awareness

118

518

2.02

11.50

2.1

2.6

1.00

1.02

ug/l

0.04

111

492

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

169

932

1.78

11.37

2.6

2.4

1.17

ug/l

0.00

162

891

Injuries to the head

345

1350

1.52

11.32

2.3

2.7

1.22

1.14

ug/l

0.27

333

1278

Other diseases of upper respiratory tract

318

1068

1.55

11.26

2.5

2.8

1.17

ug/l

0.00

301

1015

Acute upper respiratory infections of multiple and unspecified sites

238

1063

1.64

11.19

2.1

2.7

1.23

1.12

ug/l

0.31

222

1021

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

307

1257

1.54

11.07

2.6

2.7

1.49

1.09

ug/l

2.31

295

1201

Dorsopathies

311

1013

1.56

11.07

2.3

2.8

0.97

1.17

ug/l

1.16

292

964

Lower back pain or/and sciatica

310

1251

1.54

11.05

2.1

2.4

1.00

1.07

ug/l

0.27

293

1184

Spinal stenosis

119

437

2.01

11.01

2.0

2.4

1.12

1.02

ug/l

0.13

113

422

Disorders of eyelid, lacrimal system and orbit

246

1118

1.61

11.00

2.2

2.6

1.21

1.14

ug/l

0.21

237

1071

Presence of other functional implants

143

518

1.89

10.97

1.8

2.6

0.98

0.96

ug/l

0.04

136

500

Personality disorders

102

492

2.08

10.96

1.5

2.5

1.19

1.04

ug/l

0.29

460

Coxibs

152

2.56

10.90

1.7

2.4

0.74

0.93

ug/l

0.47

146

Osteopathies and chondropathies

160

818

1.79

10.88

2.2

2.6

1.52

1.07

ug/l

1.45

151

779

Symptoms and signs involving the urinary system

212

959

1.67

10.87

2.5

2.6

1.20

1.12

ug/l

0.16

202

910

Autoimmune diseases related-to ILD

253

1331

1.59

10.85

2.2

2.5

1.26

1.03

ug/l

0.93

232

1267

Diaphragmatic hernia

441

2.14

10.85

2.0

2.4

0.80

1.01

ug/l

0.85

419

Complications of medical and surgical care

203

1095

1.67

10.70

2.4

2.5

1.09

1.14

ug/l

0.13

194

1043

Malignant neoplasm of other endocrine glands and related structures

+∞

10.69

6.9

0.0

2.14

—

ug/l

—

Pure hypercholesterolaemia

179

649

1.75

10.60

2.8

2.3

1.12

0.99

ug/l

0.24

173

610

Specific personality disorders

420

2.15

10.55

1.4

2.5

1.07

1.03

ug/l

0.08

392

Diabetes, varying definitions

308

1173

1.52

10.32

2.5

2.6

1.05

1.11

ug/l

0.21

284

1117

Disorders of adult personality and behaviour

107

538

2.00

10.29

1.5

2.4

1.13

1.05

ug/l

0.15

506

Constipation

255

1096

1.58

10.27

2.3

2.9

1.28

1.19

ug/l

0.23

237

1061

Diabetes mellitus

309

1176

1.52

10.19

2.5

2.6

1.05

1.12

ug/l

0.27

285

1120

Disorders of ocular muscles, binocular movement, accommodation and refraction

171

990

1.72

10.18

2.9

2.8

1.48

1.29

ug/l

0.48

166

943

Diverticular disease of intestine

161

562

1.79

10.12

3.6

2.0

1.05

0.97

ug/l

0.22

150

539

Disorders of vestibular function (Vertigo)

120

614

1.91

10.10

1.9

2.3

1.01

1.00

ug/l

0.03

112

590

Other joint disorders

280

939

1.56

10.10

2.5

2.6

1.12

1.11

ug/l

0.03

260

896

Other pulmonary diagnosis

223

679

1.65

10.04

2.0

2.9

1.17

1.05

ug/l

0.35

209

649

Benign neoplasm of colon, rectum, anus and anal canal

148

699

1.79

10.01

4.6

2.0

1.29

1.01

ug/l

0.51

142

666

Intracranial injury

180

996

1.69

9.99

2.2

2.8

1.09

1.15

ug/l

0.14

173

939

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

153

869

1.76

9.98

2.7

2.4

1.20

1.17

ug/l

0.06

146

828

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

27.80

9.96

6.4

4.4

1.91

1.56

ug/l

—

ILD differential diagnosis

222

677

1.65

9.94

2.1

2.9

1.19

1.06

ug/l

0.41

207

649

Diseases of inner ear

136

715

1.82

9.92

1.9

2.4

0.98

1.09

ug/l

0.31

127

686

Examination and observation for other reasons

144

440

1.85

9.90

3.0

2.6

1.31

1.14

ug/l

0.42

137

416

COPD differential diagnosis

222

678

1.64

9.89

2.1

2.9

1.19

1.05

ug/l

0.41

207

650

Factors influencing health status and contact with health services

174

2.34

9.87

2.7

1.45

1.19

ug/l

0.31

162

Acute upper respiratory infections

292

1150

1.52

9.85

2.2

2.7

1.16

1.13

ug/l

0.10

270

1108

Weight loss

152

2.91

9.79

1.6

3.1

1.50

1.47

ug/l

0.03

142

Falls/tendency to fall

332

1116

1.49

9.78

2.4

2.8

1.26

1.15

ug/l

0.39

308

1064

Substance abuse, excluding more controls

150

708

1.77

9.78

1.7

2.5

1.22

0.95

ug/l

0.80

138

670

Certain infectious and parasitic diseases, including avohilmo

210

635

1.66

9.72

2.5

2.9

1.12

1.20

ug/l

0.20

193

604

Dentofacial anomalies [including malocclusion]

233

1157

1.58

9.66

2.9

2.6

1.16

1.14

ug/l

0.05

226

1094

Excluding asthma or asthma-COPD overlap

221

679

1.63

9.63

2.1

2.9

1.18

1.05

ug/l

0.39

208

649

Use of hypnotics and sedatives

300

1139

1.51

9.55

1.9

2.7

0.98

1.11

ug/l

0.58

284

1075

Other and unspecified iron deficiency

498

1.99

9.49

2.4

2.8

1.44

1.22

ug/l

0.56

478

Diseases of male genital organs

171

495

1.74

9.47

2.6

3.2

0.98

1.06

ug/l

0.17

154

465

Persons encountering health services for specific procedures and health care

330

1324

1.47

9.46

2.6

2.7

1.27

1.13

ug/l

0.42

320

1250

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

128

431

1.87

9.45

2.3

2.4

1.76

1.03

ug/l

1.33

118

408

Other bacterial diseases, including avohilmo

304

1272

1.49

9.44

2.3

2.8

1.19

1.15

ug/l

0.09

288

1208

Finngen Rheumatological endpoints

290

1089

1.51

9.41

2.3

2.5

1.08

ug/l

0.00

264

1038

Epilepsy

440

2.04

9.31

2.8

3.6

1.57

1.41

ug/l

0.24

429

Other (not insulin) diabetes medications

266

1018

1.53

9.30

2.4

2.3

1.01

ug/l

0.02

242

972

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

289

2.29

9.10

1.3

2.4

1.09

0.97

ug/l

0.23

267

Soft tissue disorders related to use, overuse and pressure

337

2.17

8.86

1.5

2.6

1.15

1.05

ug/l

0.20

325

Influenza and pneumonia

321

1363

1.45

8.76

2.3

2.7

1.13

1.16

ug/l

0.13

303

1296

Iron deficiency anaemia

115

614

1.84

8.76

2.4

2.8

1.35

1.18

ug/l

0.46

101

590

Certain infectious and parasitic diseases

287

962

1.50

8.65

2.5

2.8

1.25

1.16

ug/l

0.25

269

917

Acute sinusitis

163

894

1.66

8.57

1.9

2.6

0.92

1.08

ug/l

0.57

150

857

Symptoms and signs involving speech and voice

477

1.95

8.54

2.0

2.5

1.50

1.03

ug/l

0.94

453

Unspecified mental disorder

126

712

1.77

8.53

1.3

2.4

1.11

0.96

ug/l

0.34

117

660

Diseases of the respiratory system

181

547

1.66

8.48

2.3

3.0

1.18

1.09

ug/l

0.22

168

530

Chronic apical periodontitis

307

1179

1.46

8.45

2.5

2.4

0.89

1.12

ug/l

1.55

285

1120

Chronic rhinitis, nasopharyngitis and pharyngitis

102

542

1.89

8.42

2.1

2.8

0.96

1.21

ug/l

0.73

517

Suicide or other Intentional self-harm

420

2.01

8.31

1.2

2.4

1.11

1.05

ug/l

0.11

392

Systemic connective tissue disorders

482

1.93

8.29

1.8

2.7

1.57

1.10

ug/l

1.12

460

All kidney diseases

285

1305

1.46

8.22

2.4

2.7

1.44

1.10

ug/l

1.28

274

1241

Nutritional anaemias

127

692

1.75

8.21

2.3

2.7

1.27

1.17

ug/l

0.26

113

666

Other neurological diseases

176

844

1.62

8.20

2.5

2.4

1.18

1.07

ug/l

0.24

165

808

Arthrosis

183

616

1.63

8.17

3.0

2.2

1.05

0.92

ug/l

0.39

167

589

Other bacterial diseases

266

1190

1.48

8.13

2.3

2.7

1.27

1.11

ug/l

0.56

252

1124

Fall on same level

344

1291

1.42

8.13

2.4

2.8

1.24

1.15

ug/l

0.27

323

1230

Mental and behavioural disorders due to opioids

3.66

8.02

1.1

2.6

1.12

1.03

ug/l

0.06

Voice disturbances

385

2.03

8.01

2.1

2.4

1.22

1.04

ug/l

0.28

368

Arthropathies

279

959

1.47

7.83

2.7

2.6

1.09

1.15

ug/l

0.23

257

916

Heart failure, not strict

181

762

1.60

7.82

2.0

2.8

1.36

1.00

ug/l

1.42

174

731

Disorders of synovium and tendon

147

749

1.67

7.82

2.2

2.6

1.35

1.09

ug/l

0.40

137

720

Autoimmune diseases excluding thyroid diseases, strict definition

238

856

1.51

7.78

2.4

2.8

1.38

1.12

ug/l

0.94

223

817

Excessive, frequent and irregular menstruation

105

297

1.89

7.74

1.9

2.3

1.04

1.27

ug/l

0.56

100

286

Other/unspecified dorsalgia

100

538

1.84

7.67

1.3

2.6

0.92

1.24

ug/l

0.97

515

Artrosis, including avohilmo

215

764

1.54

7.67

2.9

2.2

0.97

1.00

ug/l

0.10

193

725

Internal derangement of knee

102

554

1.83

7.65

1.5

2.2

0.92

0.97

ug/l

0.11

526

Vasomotor and allergic rhinitis

130

748

1.70

7.64

2.3

3.0

0.92

1.31

ug/l

1.28

119

712

Abnormal findings on examination of blood, without diagnosis

120

624

1.74

7.60

2.2

2.6

1.07

ug/l

0.00

113

596

Other symptoms and signs involving the digestive system and abdomen

223

2.34

7.59

2.3

3.0

1.49

1.28

ug/l

0.21

215

Renal tubulo-interstitial diseases

239

1181

1.48

7.53

2.1

2.7

1.49

1.15

ug/l

1.34

228

1132

Cerebrovascular diseases (FINNGEN)

265

2.04

7.50

2.5

2.3

1.11

0.94

ug/l

0.31

253

Other disorders of urethra and urinary system

182

807

1.57

7.39

2.0

2.6

0.91

1.14

ug/l

1.36

176

783

Dermatitis and eczema

318

1336

1.41

7.39

2.1

2.7

1.15

ug/l

0.01

297

1273

Lack of expected normal physiological development

2.98

7.36

4.8

5.9

2.38

1.80

ug/l

0.77

Other and unspecified mood [affective] disorders

115

2.89

7.31

1.8

2.9

1.18

1.13

ug/l

0.07

107

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

245

969

1.48

7.31

2.0

2.8

1.12

1.14

ug/l

0.05

233

934

245

969

1.48

7.31

2.0

2.8

1.12

1.14

ug/l

0.05

233

934

Emotionally unstable personality disorder

223

2.30

7.15

1.5

2.4

1.24

1.00

ug/l

0.37

206

Bronchitis

299

1268

1.42

7.13

2.0

2.7

1.14

1.11

ug/l

0.10

278

1212

Other and unspecified effects of external causes

100

559

1.79

7.11

2.2

2.9

1.02

1.26

ug/l

0.62

528

Any event in cancer register

260

1046

1.45

7.10

2.2

2.6

1.22

1.13

ug/l

0.24

247

991

Carpal tunnel syndrome

149

800

1.62

7.09

2.8

2.3

1.04

1.13

ug/l

0.23

143

764

Acute tubulo-interstitial nephritis

165

884

1.58

7.07

2.2

2.7

1.27

1.20

ug/l

0.14

156

851

Cough

112

603

1.74

7.06

2.2

3.2

1.05

1.28

ug/l

0.75

104

579

Diseases of the skin and subcutaneous tissue

277

965

1.44

7.05

2.1

2.8

1.34

1.14

ug/l

0.72

256

920

Paralytic strabismus

3.31

6.96

4.1

2.2

1.56

1.15

ug/l

0.30

Injuries to the knee and lower leg

335

1308

1.39

6.94

2.3

2.7

1.02

1.18

ug/l

0.73

315

1245

Bacterial infection, other or unspecified, including avohilmo

144

728

1.62

6.92

2.2

2.8

1.13

ug/l

0.01

137

696

Covid-19 confirmed case

549

1.79

6.90

1.7

2.5

1.14

1.17

ug/l

0.05

519

Kela-code for severe mental illness

108

624

1.73

6.88

1.3

2.5

1.04

0.93

ug/l

0.21

577

Asthma, including avohilmo

336

1341

1.38

6.85

2.3

2.7

1.13

1.17

ug/l

0.12

313

1278

Benign neoplasm: Ascending colon

148

2.58

6.84

6.5

2.1

1.15

1.05

ug/l

0.14

138

Disorders of conjunctiva

250

1348

1.44

6.82

2.7

1.25

1.20

ug/l

0.12

245

1276

Other disorders of ear

244

1087

1.45

6.79

2.3

2.8

0.98

1.18

ug/l

1.00

233

1033

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

263

1440

1.42

6.78

2.4

2.7

1.00

1.19

ug/l

0.89

251

1368

Lumbar disc prolapse

162

763

1.57

6.76

2.1

2.5

0.76

1.08

ug/l

2.30

153

724

Dental pulpitis, including avohilmo

269

1211

1.42

6.74

2.2

2.5

1.03

1.08

ug/l

0.17

249

1151

Other disorders of eye and adnexa

249

2.18

6.69

3.0

3.1

1.26

1.33

ug/l

0.09

234

Urticaria and erythema

120

720

1.67

6.66

2.6

2.9

1.25

1.34

ug/l

0.21

112

689

Pneumonia, organism unspecified

265

1281

1.42

6.62

2.2

2.8

1.30

1.16

ug/l

0.46

250

1217

Endometriosis

268

1.89

6.62

1.7

2.1

1.40

1.22

ug/l

0.27

258

Sensorineural hearing loss

170

730

1.55

6.60

2.2

2.5

0.97

1.05

ug/l

0.29

162

697

Biguanides

242

1011

1.45

6.54

2.4

2.3

1.02

1.05

ug/l

0.07

221

966

All pneumoniae

297

1389

1.39

6.52

2.3

2.7

1.22

1.16

ug/l

0.17

281

1319

Polyarthropathies

180

757

1.53

6.46

2.5

2.4

1.24

1.07

ug/l

0.49

170

724

Diabetes medication

292

1223

1.40

6.45

2.4

2.6

1.06

1.11

ug/l

0.14

267

1166

Malignant neoplasm of brain, including Hilmo

3.41

6.42

4.2

3.2

0.95

1.56

ug/l

0.58

Pneumonias (Asthma/COPD co-morbidities)

293

1386

1.38

6.24

2.2

2.8

1.24

1.16

ug/l

0.25

277

1316

Other viral diseases, including avohilmo

139

873

1.58

6.20

2.7

2.9

1.30

1.32

ug/l

0.04

133

825

Hernia

248

1162

1.42

6.19

2.4

2.6

1.09

1.11

ug/l

0.05

231

1102

Shoulder lesions

177

697

1.52

6.19

2.4

2.5

0.83

1.01

ug/l

0.74

164

667

Noninfective enteritis and colitis

142

905

1.57

6.18

2.5

2.9

1.32

1.16

ug/l

0.43

134

857

Other diseases of urinary system

263

1047

1.41

6.17

2.1

2.7

1.07

1.18

ug/l

0.38

248

1009

Haemorrhoids and perianal venous thrombosis

392

1.88

6.16

1.9

0.93

0.97

ug/l

0.06

374

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

287

1384

1.38

6.14

2.3

2.7

1.26

1.15

ug/l

0.42

271

1314

Deforming dorsopathies

424

1.84

6.13

2.6

2.9

0.78

1.22

ug/l

2.18

405

Dislocation, sprain and strain of joints and ligaments of knee

177

1073

1.49

6.05

2.2

2.4

0.91

1.11

ug/l

0.69

166

1013

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

2.89

6.04

3.7

3.0

1.24

1.57

ug/l

0.27

Dental operations

139

444

1.61

6.00

2.4

2.3

1.22

1.12

ug/l

0.18

132

421

COPD/asthma related infections

271

969

1.40

6.00

2.1

2.8

1.16

1.14

ug/l

0.06

247

934

COPD/asthma/ILD related infections

271

969

1.40

6.00

2.1

2.8

1.16

1.14

ug/l

0.06

247

934

Nonorganic sleeping disorders

421

1.83

5.97

2.4

2.5

0.93

1.14

ug/l

0.43

396

Chronic lower respiratory diseases

340

1330

1.35

5.96

2.4

2.7

1.14

1.17

ug/l

0.09

319

1266

Sciatica+with lumbago

128

709

1.60

5.96

1.9

2.5

0.80

1.14

ug/l

2.26

122

679

Conjunctivitis

227

1287

1.42

5.91

2.8

2.7

1.32

1.22

ug/l

0.20

222

1215

Chronic sinusitis

109

661

1.65

5.84

2.1

2.4

0.83

1.13

ug/l

1.42

103

628

Diseases of middle ear and mastoid

182

1009

1.47

5.79

2.2

2.7

1.22

1.17

ug/l

0.11

170

950

Hyperplasia of prostate

235

1.87

5.78

1.9

2.6

0.77

0.88

ug/l

0.22

223

Other disorders of skin and subcutaneous tissue

178

1017

1.48

5.77

1.8

2.6

1.47

1.06

ug/l

1.45

172

971

Infections of the skin and subcutaneous tissue

179

1199

1.47

5.77

2.4

2.8

1.22

1.16

ug/l

0.13

167

1135

Conductive and sensorineural hearing loss

179

800

1.49

5.73

2.2

2.6

0.95

1.07

ug/l

0.48

169

764

293

1085

1.37

5.69

2.2

2.7

1.18

1.12

ug/l

0.17

270

1044

Cervical disc disorders

464

1.77

5.69

2.5

2.6

0.84

1.02

ug/l

0.58

446

Mental and behavioural disorders due to psychoactive substance use

159

969

1.50

5.68

1.6

2.4

1.21

0.93

ug/l

0.95

147

902

Other arrhythmias

169

845

1.49

5.67

1.8

2.7

1.42

1.09

ug/l

0.60

160

803

External causes of morbidity and mortality

188

635

1.49

5.67

2.5

3.0

1.25

1.20

ug/l

0.13

174

609

Cardiac arrhythmias

173

747

1.49

5.51

2.1

2.8

1.46

1.08

ug/l

0.74

165

712

Other arthrosis

118

490

1.62

5.48

2.7

2.2

0.96

0.95

ug/l

0.02

109

468

Malignant neoplasm of eye, brain and central nervous system

3.25

5.45

3.5

1.07

1.82

ug/l

0.78

Bacterial infection, other or unspecified

123

657

1.58

5.45

2.3

2.7

1.22

1.13

ug/l

0.19

118

626

Oxicams

117

2.24

5.44

2.2

0.73

1.00

ug/l

0.53

111

Erysipelas, including avohilmo

170

853

1.48

5.42

2.0

2.4

1.11

0.98

ug/l

0.35

159

804

Injuries to the wrist and hand

284

1393

1.35

5.39

2.1

2.7

1.10

1.14

ug/l

0.14

266

1327

Endometriosis of rectovaginal septum and vagina

3.03

5.37

1.4

2.1

1.33

1.16

ug/l

0.10

Meniscus derangement

127

536

1.57

5.31

2.3

2.2

0.92

0.96

ug/l

0.12

120

512

Polyglandular dysfunction

+∞

5.25

2.4

0.0

1.08

—

ug/l

—

Gonarthrosis

140

513

1.54

5.21

2.2

2.1

1.06

0.94

ug/l

0.20

129

491

Malignant neoplasm of brain

3.67

5.21

3.6

3.7

0.53

1.49

ug/l

2.27

Coxarthrosis

102

398

1.66

5.20

3.5

2.1

1.17

0.93

ug/l

0.53

385

Obsessive-compulsive disorder

120

2.51

5.19

1.9

2.8

1.13

1.20

ug/l

0.05

112

Diseases of salivary glands

523

1.69

5.18

2.1

2.5

1.06

1.08

ug/l

0.02

497

Other intervertebral disc disorders

195

811

1.43

5.16

2.3

2.5

0.79

1.08

ug/l

1.94

185

768

Other enthesopathies

405

1.78

5.14

1.8

2.6

0.77

1.01

ug/l

0.86

392

Gonarthrosis [arthrosis of knee](FG)

163

633

1.48

5.08

2.3

2.2

0.98

0.93

ug/l

0.08

151

607

Bleeding

203

1009

1.41

5.06

2.0

2.8

1.24

1.06

ug/l

0.59

194

955

Undescended testicle

3.37

5.05

6.2

6.0

1.98

2.07

ug/l

0.05

Type of accident

512

1.68

5.04

1.9

2.7

1.58

1.09

ug/l

1.14

484

Oxycodone

409

1.72

5.04

1.6

2.2

1.03

1.00

ug/l

0.04

393

Other external causes of accidental injury

223

798

1.40

5.01

2.4

2.9

1.25

1.15

ug/l

0.28

209

763

All influenza

438

1.74

5.00

2.6

3.2

0.99

1.20

ug/l

0.72

416

Dermatitis

160

1075

1.46

4.98

1.9

2.7

1.26

1.19

ug/l

0.14

147

1035

Other diseases of hard tissues of teeth

135

454

1.54

4.94

2.7

2.6

1.20

1.24

ug/l

0.08

129

432

Other acute lower respiratory infections

149

963

1.48

4.93

2.3

2.9

1.12

1.17

ug/l

0.12

137

917

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

241

1044

1.37

4.92

2.3

2.7

1.15

1.11

ug/l

0.07

223

993

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

190

1234

1.40

4.80

2.2

2.7

1.29

1.11

ug/l

0.66

181

1165

Diseases of pulp and periapical tissues, including avohilmo

276

1066

1.34

4.77

2.5

2.7

1.21

1.20

ug/l

0.02

262

1017

Accidents

221

798

1.39

4.74

2.3

2.9

1.29

1.15

ug/l

0.44

205

763

Congenital malformations, deformations and chromosomal abnormalities

177

1186

1.42

4.73

2.3

2.7

1.32

1.12

ug/l

0.67

169

1119

Substance abuse

150

955

1.46

4.72

1.7

2.4

1.22

0.93

ug/l

0.93

138

889

Other viral diseases

105

668

1.57

4.68

2.4

3.1

1.29

1.31

ug/l

0.05

634

Delayed milestone in childhood

136

2.31

4.68

5.4

5.9

2.51

2.20

ug/l

0.30

136

Leisure time condition

301

1.87

4.67

2.0

2.7

1.65

1.17

ug/l

0.69

284

Enlarged lymph nodes

191

2.10

4.65

2.2

3.3

1.29

1.12

ug/l

0.21

182

Superficial injury of lower leg

471

1.68

4.64

2.3

2.6

1.11

1.15

ug/l

0.07

448

Tracheo-bronchomalasia

14.44

4.61

1.1

3.6

0.85

1.40

ug/l

—

Zoster [herpes zoster], including avohilmo

115

726

1.53

4.58

2.0

2.5

0.93

1.10

ug/l

0.55

110

693

ILD medications: immunosuppressive drugs

176

1132

1.41

4.57

2.2

2.9

1.47

1.13

ug/l

1.17

165

1081

Disorders of gallbladder, biliary tract and pancreas

235

1079

1.36

4.57

2.4

1.00

1.10

ug/l

0.33

223

1028

Supplementary factors related to causes of morbidity and mortality classified elsewhere

566

1.61

4.54

1.9

2.7

1.62

1.05

ug/l

1.46

536

Abnormal involuntary movements

193

2.08

4.54

2.4

2.8

1.59

1.10

ug/l

0.52

181

Slow fetal growth and fetal malnutrition

3.30

4.52

5.2

6.2

2.38

ug/l

0.00

Family history of other specific disorders

6.76

4.48

1.4

3.8

0.90

1.80

ug/l

—

Noninflammatory disorders of female genital tract

303

1.63

4.47

2.0

2.4

1.12

1.26

ug/l

0.32

292

Carrier of infectious disease

4.42

4.44

1.1

2.4

0.79

1.22

ug/l

0.56

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

156

1046

1.43

4.44

2.3

2.6

1.33

1.20

ug/l

0.22

151

992

Motor disorders, excluding more controls

2.90

4.43

5.9

6.1

2.26

1.56

ug/l

0.64

Urticaria

609

1.58

4.42

2.8

3.0

1.35

1.33

ug/l

0.03

580

Allergic rhinitis

109

703

1.53

4.41

2.4

3.1

0.95

1.40

ug/l

1.29

674

Crossbite

236

1.92

4.41

6.3

4.6

1.43

1.75

ug/l

0.58

229

Any operation in hilmo

8.55

4.38

2.0

3.8

0.91

2.09

ug/l

—

Adverse effects, not elsewhere classified

389

1.73

4.36

2.1

2.9

0.94

1.32

ug/l

0.99

367

Fall on and from stairs and steps

413

1.70

4.30

1.9

2.6

1.09

1.10

ug/l

0.02

389

Disorders of skin appendages

140

964

1.45

4.28

2.3

2.6

1.02

1.19

ug/l

0.42

133

914

Viral infections characterized by skin and mucous membrane lesions

122

822

1.49

4.27

2.7

2.9

0.96

1.26

ug/l

1.15

117

782

Trigeminal neuralgia

2.92

4.17

1.6

1.9

1.41

1.11

ug/l

0.21

Ovarian cyst

275

1.67

4.16

2.1

1.04

1.26

ug/l

0.68

265

Redundant prepuce, phimosis and paraphimosis

337

1.76

4.15

2.5

3.0

0.90

0.85

ug/l

0.07

311

Rotator cuff syndrome

127

592

1.48

4.12

2.3

2.5

0.82

0.98

ug/l

0.48

119

570

Suppurative and unspecified otitis media

123

739

1.48

4.12

2.1

2.9

1.12

1.19

ug/l

0.14

114

692

Acute bronchitis

106

686

1.52

4.11

2.1

3.0

1.08

1.25

ug/l

0.53

657

Cholecystectomy

151

905

1.42

4.07

2.6

2.3

0.89

1.14

ug/l

1.03

143

868

Injury, poisoning and certain other consequences of external causes

152

532

1.43

3.98

2.2

3.1

1.21

1.31

ug/l

0.24

140

511

Conjunctivitis (acute, non atopic), including avohilmo

266

1236

1.30

3.92

2.5

2.6

1.11

ug/l

0.01

256

1166

Neuromuscular dysfunction of bladder

106

2.37

3.90

2.5

2.7

0.77

1.13

ug/l

0.76

Cholelithiasis

180

897

1.37

3.87

2.5

2.3

0.97

1.09

ug/l

0.38

169

859

Malignant neoplasm, wide definition

226

992

1.33

3.84

2.6

1.26

1.09

ug/l

0.52

215

938

Gingivitis and periodontal diseases

250

985

1.31

3.83

2.9

2.7

1.24

1.13

ug/l

0.34

237

937

Hypoglycaemia, other or unspecified

126

2.23

3.83

3.0

3.4

2.97

1.59

ug/l

1.05

118

Cholelithiasis, broad definition with cholecystitis

189

927

1.36

3.82

2.5

2.3

0.95

1.09

ug/l

0.46

177

889

Erysipelas

118

695

1.46

3.82

1.9

2.5

1.14

0.90

ug/l

0.59

111

653

142

2.16

3.79

5.3

5.5

2.76

2.21

ug/l

0.65

142

Other and unspecified disorders of autonomic nervous system

12.38

3.79

1.0

2.6

1.44

1.13

ug/l

—

Postviral fatigue syndrome

8.90

3.79

1.7

2.6

1.34

1.50

ug/l

—

Hyperprolactinaemia, drug-induced

12.31

3.78

1.7

2.6

1.46

1.82

ug/l

—

Other disorders of veins

568

1.54

3.77

1.9

2.3

0.83

0.97

ug/l

0.54

544

Persons encountering health services in circumstances related to reproduction

181

891

1.36

3.77

3.4

2.7

1.34

1.11

ug/l

0.63

174

830

Allergic conjunctivitis

161

1127

1.38

3.74

2.3

2.7

1.31

1.18

ug/l

0.23

156

1073

Acute suppurative otitis media

600

1.51

3.69

2.1

3.1

1.07

1.25

ug/l

0.53

564

Malignant neoplasm, including Hilmo

225

994

1.32

3.69

2.5

2.6

1.27

1.11

ug/l

0.47

214

940

Keratitis

622

1.51

3.67

2.0

2.6

0.99

1.12

ug/l

0.28

590

Other disorders of kidney and ureter

176

1.99

3.62

2.0

2.6

1.92

1.21

ug/l

0.85

165

Propionic acid derivatives

219

1.66

3.61

2.5

3.6

1.07

1.11

ug/l

0.06

213

Other specified congenital malformation syndromes affecting multiple systems

2.79

3.60

3.9

5.3

2.01

2.29

ug/l

0.16

Other and unspecified dermatitis

128

903

1.42

3.60

1.9

2.8

1.27

1.23

ug/l

0.08

119

872

Open wound of wrist and hand

126

856

1.42

3.59

1.9

2.5

1.01

1.07

ug/l

0.14

117

799

Chronic diseases of tonsils and adenoids

210

1001

1.32

3.59

2.7

2.8

1.24

1.20

ug/l

0.11

198

948

Dental caries, including avohilmo

173

646

1.37

3.59

2.8

2.7

1.18

1.20

ug/l

0.04

165

615

Other skin changes

269

1.79

3.59

2.1

2.7

1.42

1.04

ug/l

0.66

257

Cystitis

198

884

1.33

3.52

2.2

2.7

1.16

1.20

ug/l

0.11

185

857

157

2.04

3.52

5.4

2.64

2.11

ug/l

0.65

157

Necrosis of pulp, including avohilmo

157

1138

1.36

3.51

2.7

2.4

1.09

ug/l

0.00

147

1074

Haemorrhage, not elsewhere classified

3.89

3.49

2.3

3.4

1.28

1.49

ug/l

0.20

Transport accidents

123

719

1.42

3.47

1.7

2.8

1.26

1.04

ug/l

0.49

117

684

Periapical abscess

122

860

1.42

3.47

2.4

2.7

0.79

1.13

ug/l

2.13

115

810

Gonarthrosis,primary

174

775

1.35

3.46

2.1

2.3

0.80

1.01

ug/l

1.16

162

741

Open wound of head

140

951

1.38

3.40

2.9

1.12

1.08

ug/l

0.08

135

889

Coxarthrosis [arthrosis of hip](FG)

104

486

1.47

3.40

3.4

2.3

1.17

0.92

ug/l

0.61

472

Excessive attrition of teeth

168

1240

1.34

3.39

2.4

2.6

1.31

1.13

ug/l

0.51

160

1179

Injuries to the abdomen, lower back, lumbar spine and pelvis

648

1.48

3.39

1.8

2.5

1.22

1.09

ug/l

0.33

617

Malignant neoplasm of adrenal gland, including Hilmo

7.15

3.38

2.1

5.5

1.88

1.82

ug/l

—

Osteonecrosis

2.58

3.38

1.7

2.7

0.89

1.18

ug/l

0.46

Diabetes, insulin treatment (Kela reimbursement)

247

1146

1.28

3.36

2.3

2.7

1.13

1.10

ug/l

0.06

229

1086

Nephropathy related operations

196

1.89

3.33

2.6

3.3

2.61

1.28

ug/l

1.74

184

Other disorders of glucose regulation and pancreatic internal secretion

148

2.03

3.30

3.2

3.4

2.95

1.51

ug/l

1.23

138

Ischemic heart diseases

192

866

1.32

3.24

2.4

2.8

1.16

1.06

ug/l

0.30

185

819

Venous thromboembolism

102

680

1.45

3.21

1.8

2.4

1.01

1.03

ug/l

0.03

649

Pain in thoracic spine

206

1.85

3.20

2.0

2.5

0.64

1.22

ug/l

2.23

194

Other and unspecified tonsillitis

111

647

1.43

3.20

2.7

3.0

1.19

1.10

ug/l

0.18

103

614

Other disorders involving the immune mechanism, not elsewhere classified

2.88

3.19

2.4

3.7

1.13

1.56

ug/l

0.28

Appendectomy

163

1164

1.33

3.17

2.1

2.4

1.18

1.04

ug/l

0.34

152

1096

Extracorporeal dialysis

2.36

3.15

2.4

3.1

2.66

1.37

ug/l

0.89

Other specified and unspecified strabismus

4.57

3.12

4.0

4.4

0.89

1.50

ug/l

—

Disorders of sclera, cornea, iris and ciliary body

134

980

1.37

3.11

2.5

1.05

1.15

ug/l

0.23

125

926

Diseases of liver

516

1.51

3.11

2.1

2.6

1.09

1.01

ug/l

0.14

490

Other congenital malformations

230

1.79

3.10

2.9

4.0

1.72

1.62

ug/l

0.11

222

Mental disorders, not otherwise specified

138

2.04

3.10

1.5

2.4

1.22

1.03

ug/l

0.18

128

Pollen allergy

501

1.52

3.10

2.6

3.4

1.05

1.44

ug/l

0.73

478

Single delivery by forceps and vacuum extractor

200

0.39

3.08

1.2

1.8

2.35

1.00

ug/l

1.31

188

Solid cancers, including Hilmo

213

961

1.29

3.08

2.5

2.6

1.27

1.08

ug/l

0.58

203

907

Other congenital malformations, including avohilmo

306

1.67

3.06

2.9

3.6

1.58

1.54

ug/l

0.06

292

Other diseases of stomach and duodenum

2.59

3.04

1.5

2.0

1.27

0.93

ug/l

0.19

Pain associated with micturition

174

1.90

3.04

1.8

2.9

0.98

1.22

ug/l

0.41

165

Nonsuppurative otitis media

463

1.50

3.01

3.2

3.0

1.88

1.35

ug/l

0.86

439

Other osteochondrodysplasias

4.37

3.01

3.3

5.4

0.34

2.36

ug/l

—

Gonarthrosis, primary, with knee surgery

101

548

1.44

2.99

2.0

2.3

0.84

1.06

ug/l

0.80

529

Fracture of lower leg, including ankle

131

945

1.36

2.96

2.2

2.6

1.05

1.10

ug/l

0.12

124

892

Dialysis, with operation codes

190

1.85

2.96

2.8

3.2

2.68

1.26

ug/l

1.84

180

Transplanted organ and tissue status

176

1.88

2.94

3.3

3.6

2.71

1.35

ug/l

2.12

165

Other or unspecified ileus, impaction or obstruction

198

1.82

2.92

2.7

2.1

1.09

1.05

ug/l

0.05

192

Excessive earwax

145

982

1.34

2.91

2.8

2.7

1.16

1.09

ug/l

0.18

135

942

Other congenital malformations of nervous system

3.77

2.90

6.5

4.6

1.76

1.69

ug/l

—

Diseases of pulp and periapical tissues and dental caries

150

571

1.35

2.88

2.7

1.28

1.22

ug/l

0.14

144

542

Benign intracranial hypertension

5.46

2.88

1.6

2.1

2.19

1.88

ug/l

—

Portal vein thrombosis

5.43

2.87

2.3

4.5

3.08

1.09

ug/l

—

Mycoses, including avohilmo

233

1411

1.26

2.86

2.4

2.5

1.19

1.09

ug/l

0.34

219

1339

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

494

1.50

2.86

1.8

2.5

0.82

1.00

ug/l

0.52

463

Melanocytic naevi, other sites/unspecified

136

1.99

2.85

2.6

2.4

1.14

1.28

ug/l

0.18

127

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.79

2.82

2.5

3.8

1.19

1.50

ug/l

0.19

Care involving dialysis

123

2.04

2.81

2.9

3.4

2.89

1.31

ug/l

1.56

117

Specific developmental disorder of motor function

2.21

2.80

5.8

5.9

2.51

1.80

ug/l

0.61

Arnold-Chiari syndrome

3.99

2.79

7.1

4.6

1.82

1.86

ug/l

—

Turner's syndrome

8.71

2.78

7.0

4.2

2.93

1.90

ug/l

—

Artificial joint operation, meniscal resection

188

933

1.29

2.76

2.1

2.4

0.90

0.96

ug/l

0.23

178

885

Anti-inflammatory and antirheumatic products, non-steroids

220

1.56

2.76

2.4

3.6

1.06

1.11

ug/l

0.08

214

Special screening examination for infectious and parasitic diseases

261

1.59

2.75

2.3

2.2

1.71

0.96

ug/l

1.35

240

L04AX Other immunosuppressants

140

1053

1.33

2.75

2.3

2.8

1.35

1.15

ug/l

0.54

132

1002

Monoamine oxidase A inhibitors

131

1.99

2.74

1.4

2.3

0.69

1.04

ug/l

0.76

121

Cluster headache, strict, including avohilmo

2.25

2.70

2.1

2.5

0.40

1.02

ug/l

2.77

Anorexia (incl.atypical)

2.15

2.70

1.7

2.5

1.53

0.97

ug/l

0.68

Exposure to other specified factors

214

1462

1.26

2.69

2.5

2.7

1.02

1.15

ug/l

0.49

204

1386

Other heart diseases, wide

249

1213

1.24

2.69

2.1

2.8

1.40

1.13

ug/l

0.71

236

1150

Atopic dermatitis

173

1067

1.29

2.68

2.6

2.8

1.16

1.20

ug/l

0.10

164

1015

Hard cardiovascular diseases

196

907

1.28

2.66

2.4

2.9

1.25

1.06

ug/l

0.62

187

860

Undescended testis, unilateral

3.00

2.65

6.6

6.1

2.02

2.30

ug/l

0.16

Cluster headache, wide,, including avohilmo

2.22

2.63

2.1

2.5

0.40

1.01

ug/l

2.72

Atrial fibrillation and flutter with reimbursement

154

1.72

2.63

2.3

2.1

1.53

0.77

ug/l

1.13

146

Other diseases of liver

281

1.64

2.62

1.6

2.6

0.94

1.06

ug/l

0.13

266

Diseases of oral cavity, salivary glands and jaws

121

455

1.37

2.62

2.4

2.6

1.39

1.24

ug/l

0.27

115

433

Rosacea

191

1.78

2.61

2.0

2.3

1.02

1.07

ug/l

0.04

182

DVT of lower extremities and pulmonary embolism

511

1.46

2.59

1.9

2.4

0.91

1.05

ug/l

0.32

485

Urinary track infection

146

551

1.33

2.57

2.3

2.6

1.30

1.32

ug/l

0.04

138

540

Injuries to the ankle and foot

202

1372

1.26

2.57

2.1

2.7

1.18

1.15

ug/l

0.10

191

1299

Personal history of other diseases and conditions

282

1.63

2.55

5.0

3.6

2.12

1.37

ug/l

1.28

270

Hernia of abdominal wall

716

1.38

2.54

2.0

2.6

1.08

1.05

ug/l

0.06

681

Malignant neoplasm

207

963

1.26

2.52

2.3

2.6

1.28

1.10

ug/l

0.53

197

910

Nonsuppurative otitis media, including avohilmo

611

1.39

2.51

2.8

1.45

1.27

ug/l

0.31

580

Malignant neoplasm

208

969

1.26

2.51

2.5

2.6

1.28

1.09

ug/l

0.53

198

916

Other and unspecified rosacea

122

1.97

2.50

1.8

1.9

1.17

1.19

ug/l

0.01

116

Dipeptidyl peptidase 4 (DPP-4) inhibitors

541

1.39

2.47

2.1

2.3

0.74

0.95

ug/l

0.94

522

Asthma/COPD (KELA code 203)

244

1327

1.23

2.45

2.4

2.7

1.16

ug/l

0.01

229

1264

Second line medication for Crohn's disease

145

1116

1.30

2.45

2.3

2.7

1.37

1.13

ug/l

0.70

137

1060

Caries of dentine, including avohilmo

181

726

1.27

2.40

2.7

2.8

1.16

1.27

ug/l

0.35

173

692

Maxillary retrognathism

2.64

2.37

6.3

4.3

0.77

1.67

ug/l

1.25

Striking against or struck by other objects

101

743

1.36

2.34

2.5

2.8

1.41

1.11

ug/l

0.71

692

Bilateral cryptorchidism (undescended testicles)

3.75

2.34

6.2

6.6

2.23

3.06

ug/l

—

Sequelae of injuries of head

2.19

2.31

1.6

2.5

0.86

1.01

ug/l

0.18

Other disorders of bone

341

1.53

2.25

1.8

2.7

1.22

1.06

ug/l

0.16

319

Sudden idiopathic hearing loss

113

1.95

2.25

2.5

2.2

0.76

1.06

ug/l

0.59

107

Other heart diseases

126

623

1.32

2.23

2.3

3.1

1.47

1.14

ug/l

0.76

118

590

Varus deformity, not elsewhere classified

5.60

2.22

5.6

3.7

1.50

1.21

ug/l

—

Caries of enamel

248

1339

1.21

2.21

2.9

2.5

1.28

1.11

ug/l

0.64

236

1266

Disease of hard tissues of teeth, NOS

113

441

1.34

2.21

2.3

2.5

1.06

1.17

ug/l

0.22

104

419

138

934

1.29

2.17

1.6

2.4

1.24

0.91

ug/l

0.98

127

868

Inflammatory diseases of prostate (prostatitis)

129

1.86

2.16

2.5

2.8

0.46

0.67

ug/l

0.49

123

Anosmia

5.33

2.14

2.4

1.3

0.33

0.50

ug/l

—

Dementia

272

1.48

2.13

1.9

2.3

1.53

0.94

ug/l

1.17

258

Provisional assignment of new diseases of uncertain etiology

126

966

1.29

2.12

2.1

2.6

1.11

1.24

ug/l

0.35

119

918

Unspecified fall

124

939

1.30

2.12

2.4

2.9

0.96

1.20

ug/l

1.11

119

892

Dementia, including avohilmo

300

1.46

2.11

2.1

2.4

1.50

0.97

ug/l

1.12

286

Agranulocytosis

167

1.74

2.11

2.1

2.8

1.34

1.41

ug/l

0.06

158

Hypermetropia

167

1.74

2.10

3.7

4.3

1.83

1.54

ug/l

0.28

160

Other maternal disorders predominantly related to pregnancy

130

627

1.30

2.10

2.1

2.3

1.18

1.23

ug/l

0.11

124

608

Codes for special purposes

126

968

1.29

2.09

2.1

2.6

1.11

1.23

ug/l

0.34

119

920

Certain conditions originating in the perinatal period

237

1.58

2.08

4.9

4.1

1.82

1.49

ug/l

0.50

230

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.34

2.07

1.9

2.8

1.18

0.87

ug/l

0.36

Other noninflammatory disorders of vulva and perineum

110

1.91

2.05

2.0

1.9

1.40

1.31

ug/l

0.07

105

Diseases of appendix

175

1263

1.24

2.04

2.3

2.4

1.15

1.02

ug/l

0.32

164

1191

4.04

2.04

1.0

2.6

0.43

1.26

ug/l

—

LeFortI or BSSO operation

2.12

2.02

3.7

2.4

0.70

0.95

ug/l

0.51

Other and unspecified injuries of ankle and foot

2.11

2.02

2.0

3.1

2.05

1.12

ug/l

1.12

Hypoplasia of dental enamel

2.01

4.6

6.5

3.04

2.01

ug/l

0.74

Coxarthrosis, primary

618

1.33

2.01

3.6

2.2

1.18

1.00

ug/l

0.36

596

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

208

1078

1.22

2.00

2.5

2.4

1.42

1.01

ug/l

1.14

196

1027

Injuries to the shoulder and upper arm

199

1258

1.22

1.99

2.0

2.6

1.05

1.03

ug/l

0.05

185

1189

Open wound of neck

4.60

1.95

1.0

3.3

0.52

1.68

ug/l

—

Non-Hodgkin lymphoma, all, including Hilmo

134

1.79

1.94

2.5

2.6

0.98

1.02

ug/l

0.04

123

Open bite that required surgery (Lefort1 or BSSO)

4.59

1.94

1.2

2.4

0.93

1.55

ug/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

4.58

1.94

1.0

2.5

0.97

1.16

ug/l

—

Labour and delivery complicated by fetal stress [distress]

359

0.63

1.94

2.1

1.46

1.18

ug/l

0.38

343

Other abnormal findings in urine

3.78

1.94

2.0

3.4

1.57

1.93

ug/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

563

1.37

1.93

1.6

2.5

1.13

1.16

ug/l

0.03

529

Periodontitis

221

1168

1.21

1.92

2.7

2.2

1.04

1.03

ug/l

0.02

207

1102

Monosomies and deletions from the autosomes, not elsewhere classified

3.33

1.91

3.7

6.1

4.07

2.59

ug/l

—

Drug-induced neutropenia

2.06

1.90

1.5

2.0

0.52

1.20

ug/l

2.08

Respiratory and cardiovascular disorders specific to the perinatal period

161

1.69

1.90

5.9

5.6

2.66

2.08

ug/l

0.61

161

Chronic periodontitis, including avohilmo

220

1165

1.20

1.90

2.8

2.2

1.04

ug/l

0.01

207

1099

Reimbursement for rheumatic diseases

122

950

1.28

1.89

2.7

2.6

1.47

1.17

ug/l

0.77

117

909

Hypertensive Renal Disease

3.19

1.88

1.4

2.1

0.68

0.77

ug/l

—

L01XX Other antineoplastic agents

2.31

1.87

2.8

1.8

1.19

1.12

ug/l

0.06

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

133

816

1.27

1.87

1.9

2.3

1.27

1.13

ug/l

0.34

126

786

Motor disorders

114

1.86

1.85

5.8

5.9

2.51

2.00

ug/l

0.38

114

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.98

1.85

1.4

2.2

0.76

1.08

ug/l

0.55

Appendicitis, broad definition

172

1260

1.22

1.84

2.3

2.4

1.15

1.02

ug/l

0.34

161

1189

Central nervous system disorder causing precocious puberty

4.32

1.84

3.6

5.8

0.84

1.59

ug/l

—

Congenital ptosis

4.29

1.84

3.6

4.0

3.70

3.44

ug/l

—

Diseases of arteries, arterioles and capillaries

117

671

1.28

1.79

2.3

2.4

1.66

0.95

ug/l

1.20

112

639

Macular pucker

153

1.70

1.79

2.5

2.0

0.63

1.01

ug/l

1.04

145

Iron deficiency anaemia secondary to blood loss (chronic)

177

1.64

1.75

1.6

2.5

1.57

1.07

ug/l

0.46

171

Congenital ptosis, including avohilmo

3.94

1.73

3.6

3.8

3.70

3.18

ug/l

—

Primary gonarthrosis, bilateral

530

1.33

1.73

2.0

2.3

0.85

1.02

ug/l

0.53

509

Routine general health check-up of defined subpopulation

2.68

1.72

2.8

6.11

0.94

ug/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

3.86

1.71

1.0

2.9

0.71

0.98

ug/l

—

Benign neoplasm: Skin of other and unspecified parts of face

118

1.78

1.70

2.7

2.0

0.96

1.22

ug/l

0.23

110

Family history of malignant neoplasm

156

1.67

1.68

3.2

2.4

1.85

1.05

ug/l

0.77

146

Fracture of lumbar spine and pelvis

258

1.51

1.68

1.3

2.4

1.58

1.15

ug/l

0.81

245

Mental and behavioural disorders due to alcohol

112

842

1.27

1.67

1.6

2.3

1.25

0.90

ug/l

0.92

102

783

Allergic asthma (mode)

398

1.40

1.66

2.4

3.0

0.98

1.18

ug/l

0.38

380

Cerebrovascular diseases

130

722

1.25

1.65

2.2

2.5

1.06

0.98

ug/l

0.19

121

692

Acute appendicitis

161

1230

1.21

1.64

2.3

2.4

1.16

1.01

ug/l

0.35

151

1159

Assault by bodily force

150

1.67

1.63

2.3

2.8

1.20

1.01

ug/l

0.15

140

Malignant melanoma of skin, including Hilmo

150

1.67

1.62

2.3

0.96

0.99

ug/l

0.04

139

Primary_lymphoid and hematopoietic malignant neoplasms

302

1.46

1.62

2.3

2.7

1.00

1.13

ug/l

0.23

285

Other chromosome abnormalities, not elsewhere classified

2.57

1.62

4.4

6.5

1.81

2.35

ug/l

—

STROKE

108

571

1.27

1.61

2.5

2.6

1.23

0.97

ug/l

0.64

100

542

Allergic asthma (mode), excluding more controls

401

1.39

1.60

2.4

3.0

0.98

1.16

ug/l

0.34

383

Chronic respiratory disease originating in the perinatal period

3.14

1.60

6.2

5.9

2.58

2.68

ug/l

—

Solid cancers

188

918

1.20

1.60

2.3

2.5

1.31

1.08

ug/l

0.65

179

869

Other noninflammatory disorders of vagina

1.91

1.59

1.9

2.0

1.21

1.40

ug/l

0.15

Prominent ears

3.03

1.58

1.7

4.7

2.01

1.35

ug/l

—

Premenstrual syndrome

3.02

1.58

4.8

2.1

1.10

1.36

ug/l

—

Other congenital malformations of male genital organs

2.32

1.57

6.6

6.0

1.97

2.19

ug/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

2.49

1.55

5.8

6.1

1.94

2.25

ug/l

—

Hypospadias

3.41

1.53

5.4

6.1

1.80

3.44

ug/l

—

Disorders of lens

125

623

1.24

1.53

2.2

2.5

1.03

1.00

ug/l

0.05

120

593

Squamous cell neoplasms and carcinomas of the skin

2.03

1.53

1.4

1.9

1.17

1.22

ug/l

0.04

Coarctation of the aorta

0.00

1.53

0.0

5.2

—

2.01

—

Congenital malformations of cardiac chambers and connections

0.00

1.53

0.0

5.8

—

2.10

—

Other diseases of lip and oral mucosa

711

1.28

1.52

1.5

2.6

1.32

1.11

ug/l

0.35

676

Visual impairment including blindness (binocular or monocular)

1.90

1.49

4.9

2.8

0.81

1.64

ug/l

1.13

Otitis externa, unspecified

202

1.54

1.48

2.4

3.2

0.91

1.35

ug/l

1.26

191

Fracture of shoulder and upper arm

590

1.30

1.48

2.4

2.9

1.55

1.14

ug/l

0.80

560

Allergic colitis

1.82

1.47

4.5

5.5

2.72

1.97

ug/l

0.32

Other and unspecified urticaria

393

1.38

1.47

2.9

3.0

1.26

1.34

ug/l

0.12

372

Alcohol use disorder, Swedish definition

117

860

1.24

1.45

1.7

2.3

1.33

0.89

ug/l

1.22

107

796

Other diseases of pancreas

102

1.77

1.44

1.5

2.3

1.17

1.18

ug/l

0.00

Cyst of kidney

1.88

1.44

1.3

1.9

0.67

1.20

ug/l

0.83

Personal history of risk-factors, not elsewhere classified

2.74

1.43

3.2

3.1

1.47

2.58

ug/l

—

Mandibular prognathia

2.33

1.43

7.6

5.1

1.12

1.69

ug/l

—

Insulin, intermediate and long-acting

115

898

1.24

1.43

2.5

2.8

1.46

1.04

ug/l

0.68

109

850

Malignant melanoma of skin

125

1.68

1.43

2.5

2.4

1.11

0.93

ug/l

0.25

115

L04AD Calcineurin inhibitors

220

1.50

1.43

3.4

3.6

2.37

1.36

ug/l

1.36

205

Varicose veins

593

1.26

1.42

2.8

2.3

1.33

0.97

ug/l

0.45

571

Adjustment and management of implanted device

180

1.56

1.42

2.2

2.6

1.12

1.18

ug/l

0.08

171

Noninfectious colitis NAS

221

1.50

1.40

2.9

3.1

1.49

1.31

ug/l

0.24

207

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

2.44

1.39

6.4

5.9

0.71

1.63

ug/l

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.42

1.39

1.0

2.0

2.30

1.27

ug/l

—

Injury of muscle and tendon at shoulder and upper arm level

492

1.32

1.39

1.5

2.4

0.81

0.94

ug/l

0.28

466

Calculus of lower urinary tract

2.01

1.38

3.6

1.8

0.56

1.05

ug/l

1.06

Coagulation defects, purpura and other haemorrhagic conditions

330

1.40

1.38

2.2

2.9

1.36

1.17

ug/l

0.22

313

Perineal laceration during delivery

302

0.64

1.37

2.0

2.1

1.65

1.05

ug/l

0.51

286

Statin medication

158

742

1.20

1.37

2.5

2.3

1.00

1.14

ug/l

0.38

147

704

Complications associated with artificial fertilization

2.62

1.37

1.5

2.0

1.14

1.25

ug/l

—

Acute appendicitis, no complications

130

1066

1.21

1.37

2.4

1.05

1.03

ug/l

0.04

123

1003

Myositis

2.62

1.37

1.5

3.3

0.52

1.08

ug/l

—

Outcome of delivery

208

0.62

1.36

2.7

2.0

1.31

1.10

ug/l

0.21

199

Benign neoplasm: Transverse colon

127

1.66

1.36

6.5

1.9

0.96

1.02

ug/l

0.08

120

Somnolence

2.96

1.36

3.4

2.4

0.33

1.27

ug/l

—

Benign neoplasm: Lip

2.95

1.36

4.4

2.2

0.81

ug/l

—

Acute bronchiolitis

208

1.48

1.36

4.6

4.5

1.92

1.79

ug/l

0.10

201

Purpura and other haemorrhagic conditions

223

1.48

1.35

1.8

3.0

1.21

1.36

ug/l

0.20

210

Contusion of other and unspecified parts of foot

112

1.70

1.35

2.6

3.3

1.14

1.38

ug/l

0.30

104

Other congenital malformations of male genital organs, including avohilmo

2.17

1.35

6.6

5.9

1.97

2.16

ug/l

—

Alcohol use disorder, ICD-based

698

1.26

1.34

1.6

2.3

1.41

0.91

ug/l

1.11

649

124

911

1.22

1.33

1.7

2.3

1.19

0.90

ug/l

0.81

114

846

Psoriasis

427

1.34

1.32

2.9

2.4

1.14

0.98

ug/l

0.17

404

Cholangitis (primary sclerosing, PSC)

1.81

1.31

2.5

3.2

3.37

1.50

ug/l

0.85

Poisoning by medicine, drug-induced

2.79

1.29

1.4

2.2

0.53

1.11

ug/l

—

conjunctival haemorrhage

1.76

1.29

1.7

2.6

0.87

1.44

ug/l

0.93

Senile cataract

105

516

1.24

1.27

2.0

2.5

0.89

0.99

ug/l

0.22

100

496

Thrombocytopenia, unspecified

1.72

1.27

1.4

2.8

1.19

1.41

ug/l

0.27

Other inflammatory liver diseases

1.79

1.27

1.4

2.7

1.95

1.20

ug/l

0.37

Multiple myeloma, including Hilmo

2.29

1.27

1.1

1.8

0.92

1.45

ug/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

742

1.24

1.26

1.6

2.3

1.35

0.90

ug/l

1.01

687

5-aminosalicylic acid

362

1.36

1.25

2.2

2.9

1.28

1.15

ug/l

0.26

339

Disorders of continuity of bone

162

1.55

1.25

3.0

2.8

1.43

1.30

ug/l

0.17

151

Ectopic testis

2.05

1.25

6.3

6.0

2.11

2.16

ug/l

—

Percutaneous Coronary Intervention

162

833

1.18

1.25

2.6

2.9

1.18

1.08

ug/l

0.26

156

790

Injuries to the elbow and forearm

169

1235

1.17

1.24

2.1

2.7

1.29

1.17

ug/l

0.31

161

1172

Coronary revascularization (ANGIO or CABG)

162

833

1.18

1.23

2.6

2.9

1.18

1.08

ug/l

0.26

156

790

Other acute viral hepatitis

2.65

1.22

1.4

1.8

2.55

0.92

ug/l

—

Polyarteritis nodosa and related conditions

2.65

1.22

1.2

4.5

2.38

1.89

ug/l

—

Coxarthrosis, primary, with hip surgery

483

1.29

1.21

4.6

2.2

1.45

0.97

ug/l

0.91

469

Tonsillectomy and adenotomy

170

1010

1.17

1.20

2.9

2.8

1.28

1.26

ug/l

0.04

158

953

Respiratory distress of newborn

130

1.59

1.20

5.6

5.9

2.98

2.30

ug/l

0.61

130

Other inflammation of eyelid

213

1.46

1.20

2.0

3.0

0.86

1.28

ug/l

0.72

202

Hypoplasia of dental enamel, prenatal

2.19

1.20

4.5

6.2

3.85

2.31

ug/l

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.33

1.19

3.5

5.0

4.08

1.10

ug/l

—

Injury of nerves and spinal cord at neck level

2.32

1.19

1.0

2.4

3.99

0.84

ug/l

—

Hordeolum and other deep inflammation of eyelid

109

1.66

1.18

2.8

3.4

0.81

1.40

ug/l

1.17

102

Pre-eclampsia or poor fetal growth

548

1.27

1.17

1.9

2.2

1.05

1.33

ug/l

0.96

524

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

133

1.58

1.17

1.1

2.2

1.06

1.10

ug/l

0.06

127

Use of antiglaucoma preparations and miotics

1.93

1.17

1.3

1.9

3.31

1.30

ug/l

0.74

Other dialysis

2.01

1.16

3.5

3.2

2.68

1.08

ug/l

—

Varicella [chickenpox]

102

1.67

1.16

2.1

4.3

0.52

1.63

ug/l

3.82

Complications of labour and delivery

615

0.81

1.14

2.0

2.2

1.22

1.17

ug/l

0.09

597

Hypoplasia of dental enamel, prenatal , including avohilmo

2.02

1.13

4.9

6.1

3.18

2.25

ug/l

—

Other disorders of conjunctiva

183

1.48

1.13

1.9

2.6

0.76

1.19

ug/l

1.25

171

Osteomyelitis

1.75

1.12

1.6

2.9

1.51

1.32

ug/l

0.16

Ptosis of eyelid

111

1.62

1.12

1.9

2.3

1.19

1.17

ug/l

0.02

105

Disorders of tooth development and eruption

251

1.36

1.11

3.7

3.0

1.57

1.22

ug/l

0.31

239

Pneumonia due to other infectious organisms, not elsewhere classified

1.97

1.11

2.0

2.6

0.28

1.23

ug/l

—

Other disorders of white blood cells

1.79

1.10

1.5

2.5

0.96

1.50

ug/l

0.83

Mesial bite

2.40

1.09

2.2

4.3

1.75

2.51

ug/l

—

Malignant neoplasm of pancreas, including Hilmo

1.73

1.08

3.4

1.9

0.86

0.98

ug/l

0.15

Suggestive for eosinophilic asthma

120

1.59

1.08

2.4

2.2

0.97

1.14

ug/l

0.19

110

Benign neoplasm of bone and articular cartilage

128

1.57

1.08

1.5

2.4

0.75

1.33

ug/l

1.08

118

Insulin medication

125

875

1.19

1.07

2.4

2.8

1.40

1.08

ug/l

0.51

118

834

Thyroiditis

105

1.62

1.06

1.9

2.4

1.86

0.96

ug/l

0.70

Use of memantine

142

1.47

1.06

1.7

1.8

1.42

1.16

ug/l

0.29

132

Use of other anti-dementia drugs

142

1.47

1.06

1.7

1.8

1.42

1.16

ug/l

0.29

132

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

120

1.59

1.05

6.0

5.9

2.10

2.43

ug/l

0.30

120

Major coronary heart disease event

171

885

1.16

1.04

2.5

2.8

1.16

1.07

ug/l

0.24

165

839

Adalimumab

191

0.57

1.03

1.5

2.9

0.61

1.04

ug/l

0.71

178

Bursitis of shoulder

2.28

1.03

1.6

3.8

0.77

1.03

ug/l

—

Pedal cyclist injured in other and unspecified transport accidents

196

1.43

1.02

1.6

2.9

0.87

1.26

ug/l

0.69

181

Fall on same level involving ice and snow

120

1017

1.18

1.01

2.3

2.5

1.06

ug/l

0.00

112

969

Unspecified dementia

1.83

1.00

1.5

1.7

1.93

0.92

ug/l

0.40

Seborrhoeic dermatitis

147

1.50

1.00

1.9

2.8

1.76

1.08

ug/l

0.44

138

Congenital malformations of larynx

0.00

0.99

0.0

6.0

—

2.31

—

Pre-eclampsia or eclampsia

343

1.31

0.99

1.6

2.3

1.15

1.26

ug/l

0.21

328

Phakomatoses, not elsewhere classified

2.19

0.98

2.2

3.5

0.37

1.55

ug/l

—

Perforation of tympanic membrane

158

0.57

0.98

2.2

3.0

1.28

1.21

ug/l

—

150

Varicella [chickenpox], including avohilmo

148

1.49

0.97

2.6

4.6

1.11

1.61

ug/l

0.59

142

Vascular dementia

1.81

0.97

1.2

1.4

2.00

0.87

ug/l

—

Benign neoplasm of eye and adnexa

124

1.53

0.96

2.2

2.1

3.22

1.02

ug/l

0.59

115

Degenerative macular diseases

108

1.58

0.96

2.8

2.0

1.11

1.04

ug/l

0.03

101

Insulin, combination of fast acting with intermediate-acting or long-acting

125

969

1.17

0.96

2.4

2.8

1.40

1.06

ug/l

0.57

118

919

Hypertrophy of breast in women and men

310

1.32

0.96

1.8

2.4

0.70

1.20

ug/l

2.31

292

Inguinal hernia

124

702

1.17

0.95

2.9

2.5

1.33

1.00

ug/l

0.87

119

654

Familial hypercholesterolemia, with ischemic heart disease

1.69

0.95

1.1

2.0

1.35

0.98

ug/l

0.23

Conjunctivitis (acute, non atopic)

584

1.23

0.94

3.7

3.0

1.31

1.38

ug/l

0.11

553

Ischaemic heart disease, wide definition

136

719

1.16

0.94

2.2

2.4

1.02

0.96

ug/l

0.14

130

678

Pre-eclampsia

320

1.31

0.94

1.6

2.2

1.13

1.26

ug/l

0.25

306

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.61

0.93

1.4

2.0

1.06

1.04

ug/l

0.01

Benign neoplasm: Skin, unspecified

1.73

0.92

4.0

3.1

1.58

1.15

ug/l

—

Retinal detachment with retinal break

146

0.55

0.92

5.0

2.5

0.47

1.06

ug/l

—

138

Emergency coronary revascularization (for ACS)

168

887

1.14

0.91

2.5

2.8

1.17

1.07

ug/l

0.24

161

842

Covid-19 suspected case

407

0.74

0.91

3.2

2.6

1.03

1.17

ug/l

0.23

382

Spirochaetal infections, other/unspecified

118

1.53

0.90

2.4

2.3

1.18

1.40

ug/l

0.23

113

Kidney transplant status

102

1.57

0.90

4.1

4.3

2.94

1.50

ug/l

1.59

Other and unspecified coagulation defects

1.61

0.87

2.9

2.7

1.61

1.09

ug/l

0.22

Multiple delivery

131

0.53

0.87

1.9

1.7

0.37

1.14

ug/l

—

125

IgA nephropathy (IgA glomerulonephritis)

2.01

0.87

2.7

2.0

1.89

0.71

ug/l

—

Cardiodefibrillation

385

1.27

0.87

2.2

2.4

1.00

0.99

ug/l

0.02

366

Molar incisor enamel hypoplasia, with caries

1.62

0.86

4.9

6.2

2.15

2.10

ug/l

0.03

Juvenile arthritis (FINNGEN)

120

1.50

0.85

1.4

4.1

0.51

1.50

ug/l

4.36

115

Other retinal disorders

110

715

1.17

0.85

2.2

2.4

1.22

1.05

ug/l

0.32

105

682

Additional codes for the location of defect, injury or illness

1.59

0.84

1.6

2.9

1.48

1.28

ug/l

0.12

Glomerular disorders in diseases classified elsewhere

154

1.43

0.83

2.0

2.6

2.64

1.01

ug/l

1.33

143

Pedal cyclist injured in transport accident

425

1.25

0.83

1.9

2.7

1.35

1.16

ug/l

0.28

402

Car occupant injured in other and unspecified transport accidents

336

1.28

0.82

1.7

2.4

1.25

1.17

ug/l

0.09

316

Malignant neoplasm of breast, ER-positive, including Hilmo

315

0.75

0.82

1.7

2.3

2.12

1.12

ug/l

0.92

303

Malignant neoplasm of breast, HER-positive

314

0.76

0.80

1.7

2.3

2.12

1.12

ug/l

0.92

302

Lung diseases due to external agents

147

1.43

0.79

1.1

2.4

0.69

1.21

ug/l

0.98

138

Obstructed labour due to maternal pelvic abnormality

200

0.65

0.79

3.2

2.2

0.97

1.10

ug/l

0.16

195

Impacted maxillary canine

1.83

0.79

6.0

5.4

0.70

1.93

ug/l

—

Pervasive developmental disorders excl. Autism + Asperger

1.60

0.78

4.7

5.9

1.86

1.84

ug/l

0.01

Meningitis

1.62

0.78

5.6

2.9

0.81

1.29

ug/l

0.74

Mycoses

456

1.23

0.77

1.8

2.7

0.91

1.12

ug/l

0.63

433

Inguinal hernia, bilateral

115

1.48

0.76

4.5

2.9

1.84

1.08

ug/l

0.69

107

Inguinal or femoral hernia, bilateral

115

1.48

0.76

4.5

2.9

1.84

1.08

ug/l

0.69

107

Retinal breaks without detachment

200

1.35

0.76

3.3

2.4

0.47

1.01

ug/l

3.27

190

Postmenopausal atrophic vaginitis

150

1.31

0.75

1.7

2.2

1.43

1.24

ug/l

0.24

143

Congenital aortic valve stenosis

2.11

0.75

7.2

5.3

4.49

2.44

ug/l

—

Undefined dementia

1.64

0.73

1.5

1.6

1.93

1.30

ug/l

0.22

Inflammatory disorders of breast

108

1.48

0.73

2.4

2.2

0.81

1.07

ug/l

0.35

101

Other and unspecified mental retardation

1.51

0.73

4.5

6.0

1.57

2.28

ug/l

1.01

Chronic mastoiditis

2.00

0.72

1.0

3.3

2.43

1.40

ug/l

—

Other complications of labour and delivery, not elsewhere classified

245

0.72

0.71

3.7

2.2

0.69

1.07

ug/l

0.84

232

Anxious personality disorder

1.93

0.70

1.0

2.7

2.01

1.25

ug/l

—

Fibrosis and cirrhosis of liver

1.51

0.69

4.6

2.2

2.36

1.08

ug/l

0.67

L02BA Anti-estrogens

193

0.67

0.69

1.5

2.1

0.92

1.13

ug/l

0.36

185

Cirrhosis of liver, NAS

1.53

0.68

6.6

2.3

1.44

1.18

ug/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

119

0.59

0.67

1.1

2.1

0.40

1.15

ug/l

—

112

All dysplastic lesions of the cervix uteri

510

0.81

0.67

2.3

2.2

1.46

1.29

ug/l

0.20

489

Malignant neoplasm of urinary organs, including Hilmo

119

1.43

0.66

2.1

2.7

1.47

1.00

ug/l

0.24

108

Other congenital malformations of limb(s)

1.80

0.66

5.4

4.7

1.60

2.36

ug/l

—

Foreign body in respiratory tract

0.53

0.66

1.2

3.2

2.37

1.61

ug/l

—

Injury of muscle and tendon at hip and thigh level

162

1.36

0.66

2.1

2.8

1.04

0.93

ug/l

0.14

151

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

303

1.25

0.66

4.2

2.9

0.89

1.31

ug/l

1.04

287

Myocardial infarction, with ST-elevation

167

0.66

0.65

1.8

2.4

1.19

0.99

ug/l

0.10

155

Papulosquamous disorders

614

1.17

0.65

2.7

2.6

1.02

1.03

ug/l

0.01

586

Other and unspecified disorders of vitreous body

537

1.18

0.65

2.6

2.2

0.81

1.07

ug/l

1.05

515

Malignant neoplasm of pancreas

1.61

0.65

3.6

1.8

0.63

1.08

ug/l

—

Idiopathic urticaria

1.73

0.64

1.2

2.3

2.08

1.32

ug/l

—

Alcohol dependence

395

1.22

0.64

1.7

2.4

1.49

0.95

ug/l

0.72

374

Crowding of teeth, including avohilmo

274

1.24

0.63

4.4

3.9

1.73

1.56

ug/l

0.19

266

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

856

1.14

0.63

2.1

2.7

1.11

1.19

ug/l

0.17

807

Hydronephrosis

146

1.37

0.63

2.1

2.4

1.12

1.04

ug/l

0.07

138

Familial hypercholesterolemia

129

1.40

0.63

1.1

2.4

1.40

1.04

ug/l

0.31

123

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

265

1.26

0.62

4.3

1.50

1.86

ug/l

0.54

257

Recurrent dislocation of patella

1.52

0.62

2.1

2.8

1.16

1.15

ug/l

0.01

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.62

0.0

6.9

—

2.92

—

Use of disulfiram, acamprosate or naltrexone

138

1.38

0.62

2.2

2.6

2.14

0.95

ug/l

0.83

125

Other diseases of pericardium

1.64

0.62

2.0

2.5

0.79

1.33

ug/l

—

Use of donepezil

140

1.36

0.61

1.2

1.8

0.88

1.21

ug/l

0.67

131

Malignant neoplasm of bronchus and lung

137

0.67

0.60

1.2

2.3

0.89

0.81

ug/l

0.12

126

Anorexia

0.00

0.60

0.0

2.9

—

1.18

—

Abdominal aortic aneurysm (AAA)

1.58

0.60

2.9

1.7

0.41

0.73

ug/l

—

Psoriasis vulgaris

281

1.25

0.59

2.9

2.4

0.53

0.96

ug/l

2.39

265

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

112

1.41

0.58

6.5

5.8

1.90

2.42

ug/l

0.55

112

Transitory endocrine and metabolic disorders specific to fetus and newborn

112

1.41

0.58

6.5

5.8

1.90

2.42

ug/l

0.55

112

Other congenital malformations of ear

1.72

0.58

1.7

5.3

2.01

2.07

ug/l

—

Recurrent dislocation and subluxation of joint

106

1.42

0.57

3.9

2.1

0.62

1.00

ug/l

0.91

Sulfasalazine

428

1.19

0.57

2.3

2.7

1.51

1.07

ug/l

0.67

404

Myocardial infarction, strict

406

0.84

0.57

2.2

2.5

1.07

0.89

ug/l

0.30

385

Glaucoma, exfoliation

1.48

0.57

1.3

1.9

1.41

1.17

ug/l

0.19

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.43

0.56

4.5

2.2

0.94

0.99

ug/l

0.04

Polypectomy (DHB20)

0.57

0.56

4.0

3.0

0.75

1.21

ug/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

133

1.35

0.55

3.1

2.5

0.39

1.05

ug/l

3.07

124

Dermatophytosis, including avohilmo

141

1251

1.10

0.54

2.7

2.4

0.90

1.07

ug/l

0.80

132

1178

Other pleural conditions

1.42

0.54

3.7

2.1

0.81

1.20

ug/l

0.76

Contraceptive management

581

1.13

0.53

2.1

2.2

0.79

0.90

ug/l

0.33

535

Exclusion endpoint for supernumerary teeth

1.54

0.53

5.5

5.3

1.55

2.36

ug/l

—

Exposure to other and unspecified animate mechanical forces

1.43

0.52

1.6

3.4

2.25

1.23

ug/l

—

Dementia in Alzheimer disease

1.41

0.52

1.2

2.0

1.48

1.07

ug/l

0.25

Retained placenta and membranes, without haemorrhage

192

0.73

0.52

1.6

2.2

0.94

1.08

ug/l

0.18

184

Non-small cell lung cancer, including Hilmo

125

0.67

0.52

1.2

2.3

1.24

0.85

ug/l

—

115

Other and unspecified psoriasis

1.45

0.51

2.2

2.1

0.40

1.11

ug/l

1.93

Intrahepatic Cholestasis of Pregnancy (ICP)

136

0.66

0.51

3.2

2.3

1.93

1.01

ug/l

—

130

Other mental disorders due to brain damage and dysfunction and to physical disease

109

1.38

0.50

4.3

2.1

1.19

0.83

ug/l

0.67

100

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

145

0.69

0.50

3.5

2.2

1.77

1.03

ug/l

—

138

Superficial injury of wrist and hand

426

1.17

0.50

1.9

2.9

1.18

1.23

ug/l

0.06

404

Glomerular diseases

279

1.22

0.49

2.1

3.0

2.17

1.19

ug/l

1.10

263

Other diseases of biliary tract

101

1.39

0.49

1.9

2.6

1.11

1.42

ug/l

0.29

Other and unspecified injuries of head

108

0.65

0.48

2.4

3.4

1.54

1.57

ug/l

—

100

Amiodarone users

108

0.65

0.48

1.7

2.3

1.36

1.13

ug/l

—

102

Bacterial meningitis

1.52

0.48

3.7

2.2

0.94

1.01

ug/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

119

1.35

0.48

3.7

2.2

0.62

0.94

ug/l

0.80

110

Poor fetal growth

244

1.23

0.48

2.2

0.80

1.18

ug/l

1.07

232

Malignant neoplasm of bronchus and lung, including Hilmo

167

0.75

0.47

1.3

2.6

1.07

0.83

ug/l

0.35

155

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

281

1.21

0.47

3.9

2.9

0.97

1.32

ug/l

0.72

265

Injury of other and unspecified intrathoracic organs

1.41

0.46

2.4

2.6

0.75

1.08

ug/l

0.46

AV-block

155

1.27

0.46

2.0

2.7

0.80

1.18

ug/l

0.73

145

Ischaemic Stroke, excluding all haemorrhages

508

1.13

0.46

2.3

2.5

1.10

1.00

ug/l

0.20

490

Non-small cell lung cancer

0.60

0.45

1.2

2.1

0.49

0.97

ug/l

—

Supervision of normal pregnancy

252

0.84

0.45

1.5

2.0

1.16

1.06

ug/l

0.15

240

Pneumonitis due to solids and liquids

1.40

0.44

1.1

2.5

0.56

1.43

ug/l

1.98

Congenital malformations of the urinary system

130

1.31

0.44

3.6

4.0

1.70

1.69

ug/l

0.01

124

Other congenital malformations of the digestive system

147

1.29

0.43

5.5

4.9

2.42

1.99

ug/l

0.31

142

Other congenital malformations of skin, including avohilmo

157

1.28

0.43

2.6

3.3

1.34

1.49

ug/l

0.17

150

Viral warts

184

1.25

0.43

3.7

2.9

1.37

1.33

ug/l

0.03

171

Other congenital malformations, not elsewhere classified

1.62

0.43

5.0

5.8

1.65

1.85

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

551

0.87

0.43

2.1

2.2

1.49

1.28

ug/l

0.26

528

Essential (haemorrhagic) thrombocythaemia

1.56

0.42

5.4

1.8

1.27

1.57

ug/l

—

Melanocytic naevi of other and unspecified parts of face

1.38

0.42

3.1

2.1

1.40

1.04

ug/l

0.35

Salpingitis and oophoritis

221

1.22

0.42

1.3

2.4

1.09

1.21

ug/l

0.15

211

Neonatal jaundice from other and unspecified causes

127

1.30

0.42

6.0

3.75

2.11

ug/l

1.37

127

Sacroiliitis, not elsewhere classified

1.43

0.41

3.8

2.8

0.64

1.16

ug/l

—

Fracture of forearm

114

935

1.09

0.41

2.3

2.7

1.38

1.14

ug/l

0.58

109

888

Other congenital malformations of female genitalia

0.00

0.41

0.0

3.3

—

1.54

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.41

0.0

2.2

—

1.58

—

Drug-induced hypoglycaemia without coma

0.00

0.41

0.0

3.0

—

0.93

—

Malignant neoplasm of urinary organs

105

1.33

0.41

1.3

2.6

1.28

1.00

ug/l

0.11

Defects in the complement system

0.00

0.41

0.0

5.2

—

2.24

—

Stroke, excluding SAH

565

1.11

0.40

2.3

2.5

1.28

0.97

ug/l

0.73

543

Carcinoma in situ of cervix uteri, endocervix

0.00

0.40

0.0

1.8

—

1.43

—

Carcinoma in situ of cervix uteri

186

1.24

0.40

2.0

2.1

1.88

1.15

ug/l

0.65

178

Chronic pancreatitis

141

1.28

0.40

3.0

2.3

2.33

1.02

ug/l

0.82

132

Fetus and newborn affected by maternal complications of pregnancy

1.32

0.40

5.9

6.1

2.76

2.47

ug/l

—

Shigellosis, including avohilmo

0.00

0.39

0.0

4.4

—

1.23

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.39

0.0

1.8

—

1.50

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.39

0.0

2.2

—

1.49

—

Cervical polyps

106

1.32

0.39

2.6

2.1

1.53

1.19

ug/l

0.29

101

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

261

1.19

0.39

2.0

2.6

0.94

0.91

ug/l

0.05

247

Coeliac disease

215

1.21

0.38

2.5

3.2

1.01

1.29

ug/l

0.38

205

Oral lichen planus, including avohilmo , including avohilmo

1.35

0.38

1.1

2.3

0.62

1.24

ug/l

1.86

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

136

0.73

0.37

3.5

2.1

1.77

1.11

ug/l

—

131

Infections with a predominantly sexual mode of transmission, including avohilmo

783

1.10

0.37

2.0

2.3

1.82

1.04

ug/l

2.10

739

Cardiovascular disorders originating in the perinatal period

1.48

0.36

6.7

6.0

3.00

2.40

ug/l

—

Benign neoplasm: Choroid

1.27

0.36

1.1

2.0

1.99

1.17

ug/l

—

Emphysema

0.66

0.35

1.0

2.4

3.64

0.92

ug/l

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

1.43

0.35

3.3

1.9

0.53

1.53

ug/l

—

Other congenital malformations of the digestive system, including avohilmo

170

1.23

0.35

5.2

4.9

2.47

1.95

ug/l

0.41

165

COPD-related respiratory insufficiency

117

1.28

0.35

1.5

2.1

2.81

0.92

ug/l

1.09

109

Disorders of choroid and retina

140

911

1.08

0.34

2.4

2.5

1.09

1.03

ug/l

0.12

135

863

Tic and related disorders

1.36

0.34

5.0

5.6

2.11

1.63

ug/l

—

Alcohol-induced acute pancreatitis

1.37

0.34

1.0

3.5

2.49

0.90

ug/l

—

Dislocation, sprain and strain of joints and ligaments of head

1.34

0.34

1.8

3.7

2.42

1.47

ug/l

0.36

Twin gestation

154

1.23

0.33

2.2

2.4

0.77

1.14

ug/l

0.73

148

Status post-ami

193

0.82

0.33

1.6

2.4

1.63

0.81

ug/l

1.09

181

Inflammatory bowel disease

576

1.11

0.33

2.3

2.7

1.11

1.12

ug/l

0.02

542

Hypertrophic disorders of skin

100

1.30

0.33

2.4

2.7

0.78

1.02

ug/l

0.35

Congenital malformations of the urinary system, including avohilmo

136

1.25

0.33

3.6

3.9

1.70

1.65

ug/l

0.04

129

Pregnancy with abortive outcome

123

593

1.08

0.33

2.2

2.1

1.25

1.21

ug/l

0.09

115

575

Parkinson's disease, including avohilmo

144

0.76

0.33

3.2

2.0

1.49

1.03

ug/l

0.41

135

Secondary uncertain malignant neoplasm

137

1.24

0.32

2.6

2.8

1.25

1.10

ug/l

0.12

126

Motorcycle rider injured in other and unspecified transport accidents

110

1.27

0.31

1.4

2.9

0.65

1.39

ug/l

1.76

102

HSIL lesion of the cervix uteri

348

0.86

0.31

2.4

2.2

1.66

1.16

ug/l

0.54

334

Traumatic amputation of wrist and hand

1.32

0.31

1.4

2.9

0.56

1.24

ug/l

—

Pedestrian injured in transport accident

0.71

0.30

1.4

2.5

2.38

1.33

ug/l

—

Congenital deformities of hip

1.30

0.30

2.3

4.8

2.39

2.24

ug/l

—

Stroke, including SAH

609

1.08

0.29

2.2

2.4

1.28

0.97

ug/l

0.77

582

Bacterial, viral and other infectious agents

163

0.80

0.29

3.3

3.1

1.30

1.28

ug/l

0.01

151

Multiple gestation

157

1.21

0.29

2.2

2.4

0.77

1.14

ug/l

0.72

151

Pleural plaque with presence of asbestos

1.25

0.29

1.9

1.5

0.60

0.92

ug/l

—

Embedded teeth, including avohilmo

194

1.19

0.29

3.2

2.6

1.13

ug/l

0.00

180

Parkinson's disease

141

0.78

0.29

3.2

2.1

1.49

1.02

ug/l

0.42

132

IBD patients in KELA-register

420

1.12

0.29

2.4

2.6

1.27

1.12

ug/l

0.31

393

Ventricular septal defect, a heart condition

106

0.75

0.29

3.6

5.9

4.10

2.20

ug/l

—

106

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.23

0.29

3.0

2.1

0.50

1.19

ug/l

—

Other local infections of skin and subcutaneous tissue

167

1.20

0.28

1.9

3.0

1.61

1.11

ug/l

0.40

156

Cardiac arrest

1.31

0.28

1.1

2.5

1.99

1.00

ug/l

—

Amputation

1.28

0.28

1.3

2.0

0.87

0.91

ug/l

0.03

Any death

657

0.93

0.27

1.9

2.4

1.63

0.95

ug/l

0.99

630

Pedal cyclist injured in noncollision transport accidents

205

1.17

0.27

2.4

2.8

1.80

1.11

ug/l

0.73

188

Speech therapy

364

0.88

0.27

2.6

2.5

1.08

1.15

ug/l

0.12

345

Foreign body entering into or through eye or natural orifice

139

0.79

0.27

1.6

3.3

1.92

1.41

ug/l

0.35

128

Pneumonia due to Streptococcus pneumoniae

1.21

0.26

1.9

2.7

2.71

1.36

ug/l

—

Hydrocele

113

1.24

0.26

1.9

3.2

1.63

1.02

ug/l

0.49

108

Isolated patent ductus arteriosus

1.20

0.26

3.9

6.0

3.38

2.35

ug/l

—

Acute peritonitis

1.25

0.25

2.7

2.6

3.95

1.05

ug/l

—

Transient ischemic attack

506

1.09

0.25

2.6

2.4

1.23

0.92

ug/l

0.56

490

Angina pectoris

485

1.08

0.25

1.7

2.4

1.07

0.93

ug/l

0.32

462

Secondary and unspecified malignant neoplasm of lymph nodes

105

1.24

0.24

3.0

2.5

1.47

1.19

ug/l

0.19

Parkinson's disease, strict definition

126

0.79

0.24

2.2

2.0

1.47

1.06

ug/l

—

118

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.73

0.24

2.7

2.5

0.62

1.08

ug/l

—

HSIL lesion of the cervix uteri, vagina or vulva

381

0.89

0.24

2.3

2.2

1.65

1.19

ug/l

0.53

367

Prolonged pregnancy

280

0.88

0.23

2.4

2.2

0.95

1.25

ug/l

0.43

267

Other diseases of arteries and capillaries

1.24

0.23

2.3

2.1

0.98

1.06

ug/l

0.07

Cysts of oral region, not elsewhere classified

1.25

0.22

3.7

2.8

1.14

1.17

ug/l

0.03

Malignant neoplasm of rectum

0.76

0.22

3.0

2.2

0.59

0.85

ug/l

—

Non-allergic asthma

146

0.82

0.22

3.3

3.8

2.83

1.49

ug/l

0.54

139

Viral haemorrhagic fevers, not elsewhere classified/unspecified

116

1.21

0.22

2.1

2.6

0.44

1.13

ug/l

2.42

107

Underdevelopment of the second kidney

0.00

0.21

0.0

6.3

—

3.54

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

5.5

—

0.96

—

Syndactyly, including avohilmo

0.00

0.21

0.0

5.1

—

2.90

—

Mitochondrial myopathy

0.00

0.21

0.0

3.5

—

1.93

—

Congenital cataract

0.00

0.21

0.0

4.0

—

2.76

—

Congenital lens malformations

0.00

0.21

0.0

4.0

—

2.76

—

Sequelae of burns, corrosions and frostbite

0.00

0.21

0.0

4.0

—

0.95

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.21

0.0

2.7

—

1.18

—

Benign neoplasm: Brain, infratentorial

0.00

0.21

0.0

4.6

—

1.17

—

Other diseases of gallbladder

1.19

0.21

4.4

1.8

1.12

1.42

ug/l

—

Other congenital malformations of upper alimentary tract

0.00

0.21

0.0

4.4

—

2.46

—

Otorrhagia

0.00

0.21

0.0

3.5

—

1.05

—

Ankle and foot

0.00

0.21

0.0

2.4

—

1.31

—

Peptic ulcer

0.00

0.21

0.0

3.2

—

1.52

—

Migraine with aura, drug-induced

0.00

0.21

0.0

2.5

—

1.61

—

Folate deficiency anaemia

0.00

0.21

0.0

2.1

—

1.27

—

Anoxic brain damage

0.00

0.21

0.0

3.7

—

1.15

—

Pectus excavatum

0.00

0.21

0.0

5.4

—

2.92

—

Other disorders of choroid

0.00

0.21

0.0

2.3

—

1.97

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.21

0.0

3.8

—

1.43

—

Motor neuron disease ALS

0.00

0.21

0.0

1.8

—

0.99

—

Chalazion

156

0.83

0.21

2.6

2.7

1.24

1.19

ug/l

0.04

146

Coronary artery bypass grafting

179

0.87

0.21

1.4

2.4

1.05

0.76

ug/l

0.55

169

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.16

0.21

4.6

5.1

1.93

ug/l

—

Other perinatal haematological disorders

0.00

0.21

0.0

5.9

—

2.34

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

5.8

—

3.09

—

Other coagulation defects

126

1.19

0.21

2.8

2.7

1.53

1.17

ug/l

0.16

119

Atrioventricular septal defect

0.00

0.21

0.0

4.9

—

3.11

—

Bacterial, viral and other infectious agents, including avohilmo

177

0.85

0.21

3.1

1.20

1.30

ug/l

0.06

165

Diseases caused by chlamydiae

0.00

0.21

0.0

2.7

—

1.15

—

Disorders of porphyrin and bilirubin metabolism

0.00

0.21

0.0

2.5

—

0.83

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

2.7

—

1.15

—

Aortic hypoplasia

0.00

0.20

0.0

6.3

—

3.46

—

Otosclerosis

1.25

0.20

2.1

2.4

0.80

1.18

ug/l

—

Other interstitial pulmonary diseases

166

0.84

0.20

1.9

2.5

1.32

1.22

ug/l

0.08

157

Burns and corrosions of multiple body regions

0.00

0.20

0.0

3.4

—

1.19

—

Preparatory care for dialysis

1.18

0.19

1.8

2.4

0.88

1.19

ug/l

—

Diffuse large B-cell lymphoma

1.18

0.19

1.7

1.50

1.19

ug/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.18

0.19

1.7

1.50

1.19

ug/l

—

Diffuse large B-cell lymphoma, including Hilmo

1.18

0.19

1.7

1.50

1.19

ug/l

—

ILD, hospital admissions

165

0.85

0.19

1.9

2.5

1.32

1.23

ug/l

0.08

156

Interstitial lung disease

165

0.85

0.19

1.9

2.5

1.32

1.23

ug/l

0.08

156

Interstitial lung disease endpoints

165

0.85

0.19

1.9

2.5

1.32

1.23

ug/l

0.08

156

Abnormal findings on antenatal screening of mother

165

1.15

0.19

3.5

2.1

0.65

1.24

ug/l

2.16

157

Tic disorders

1.13

0.18

5.0

5.5

2.11

1.61

ug/l

—

Cystic kidney disease

1.13

0.18

5.0

3.7

2.58

1.79

ug/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.13

0.18

1.5

1.9

1.66

0.94

ug/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

109

1.19

0.18

1.8

2.6

1.72

0.98

ug/l

0.30

Separation of retinal layers (serosa)

1.21

0.18

1.1

3.0

1.11

0.99

ug/l

—

Congenital deformities of hip, including avohilmo

1.19

0.18

2.3

4.9

2.39

2.27

ug/l

—

Contact with nonpowered hand tool

1.17

0.17

1.1

2.4

1.84

1.21

ug/l

—

Abnormal findings on examination of urine, without diagnosis

1.15

0.17

3.0

2.4

1.42

1.86

ug/l

—

Inflammatory bowel disease, strict (require KELA)

436

1.08

0.17

2.4

2.7

1.27

1.15

ug/l

0.23

410

Bicuspidal aortic valve syndrome

0.71

0.16

4.6

4.2

1.75

1.26

ug/l

—

Left ventricular outflow tract obstruction, narrow definition

120

0.83

0.16

4.7

4.3

4.66

1.63

ug/l

—

112

Caught, crushed, jammed or pinched in or between objects

101

1.19

0.16

1.7

3.2

1.77

1.27

ug/l

0.30

Pleural plaque

1.16

0.16

1.8

1.4

0.89

0.91

ug/l

—

Other congenital malformations of tongue, mouth and pharynx

1.14

0.16

5.3

5.5

1.26

2.24

ug/l

—

Antepartum haemorrhage, not elsewhere classified

151

0.86

0.15

2.0

2.4

0.99

1.19

ug/l

0.22

145

ILD, hospital admissions 1, main diag only

151

0.86

0.15

1.9

2.4

1.24

1.25

ug/l

0.00

143

Conotruncal defects

0.76

0.15

4.3

5.7

2.94

2.02

ug/l

—

Other and unspecified disorders of psychological development

1.15

0.15

4.9

6.1

4.65

1.73

ug/l

—

Alzheimer disease

168

1.11

0.15

1.3

1.8

1.49

1.11

ug/l

0.38

157

Atopic conjunctivitis

1.10

0.15

2.6

3.2

0.84

1.32

ug/l

—

Malignant neoplasm of bladder, including Hilmo

1.10

0.15

3.0

2.4

1.59

0.94

ug/l

—

Other disorders originating in the perinatal period

1.09

0.14

4.8

6.0

1.74

2.05

ug/l

—

Other respiratory diseases principally affecting the interstitium

192

0.89

0.14

2.0

2.5

1.78

1.20

ug/l

0.50

183

Peripheral artery operations in Hilmo

112

1.16

0.14

1.3

2.0

1.29

0.91

ug/l

0.33

104

Foreign body or object entering through skin

0.83

0.13

1.5

2.7

1.22

1.32

ug/l

—

Other disorders of amniotic fluid and membranes

257

1.09

0.13

3.7

2.3

1.39

1.12

ug/l

0.30

245

Acute lymphadenitis

113

1.15

0.13

2.5

3.3

0.87

1.25

ug/l

0.55

107

LSIL lesion of the cervix uteri

211

0.90

0.13

2.7

2.2

1.64

1.11

ug/l

0.40

201

Benign lipomatous neoplasm of other sites/unspecified

1.16

0.11

3.1

2.1

4.74

1.16

ug/l

0.70

Glomerulonephritis

178

0.90

0.11

2.6

3.4

2.34

1.30

ug/l

0.65

167

Benign mammary dysplasia

153

1.11

0.11

2.1

2.2

1.07

ug/l

0.00

147

Alzheimer’s disease, strict definition

139

1.10

0.11

1.2

1.8

1.51

1.13

ug/l

0.29

130

Myopia

260

1.08

0.10

1.7

2.8

0.84

1.28

ug/l

1.25

242

Other chronic obstructive pulmonary disease, including avohilmo

567

1.04

0.10

1.7

2.4

1.54

0.92

ug/l

1.35

543

Valvular operations

187

0.91

0.10

4.1

3.3

1.90

1.22

ug/l

0.57

178

Seronegative juvenile rheumatoid arthritis

1.11

0.10

1.4

4.3

0.42

1.93

ug/l

—

Right ventricular outflow tract obstruction

1.06

0.09

4.4

6.3

3.44

2.17

ug/l

—

Clear cell adenocarcinoma of kidney

1.06

0.09

1.2

2.0

0.41

1.06

ug/l

—

Convergent concomitant strabismus

124

0.89

0.09

3.9

3.7

1.11

1.42

ug/l

0.36

118

Bacterial sepsis of newborn

1.11

0.09

7.3

5.9

2.25

1.98

ug/l

—

Cystic kidney disease, including avohilmo

1.07

0.08

5.0

3.6

2.58

1.79

ug/l

—

Macular hole

1.05

0.08

1.7

2.4

0.58

1.26

ug/l

—

Other or ill-defined heart diseases

0.81

0.08

1.4

2.7

0.99

1.03

ug/l

—

Amputation of toe

1.08

0.08

1.6

1.9

0.60

1.06

ug/l

—

Carcinoma in situ of skin of other and unspecified parts of face

1.06

0.08

1.0

2.0

1.53

1.45

ug/l

—

Injury of unspecified body region

127

1.10

0.07

1.5

2.7

1.15

1.44

ug/l

0.24

119

Artificial joint re-operation

0.86

0.07

2.2

2.0

0.78

1.38

ug/l

—

Entropion and trichiasis of eyelid

0.83

0.07

1.2

2.2

1.34

1.23

ug/l

—

Hypertrophy of breast

266

0.94

0.07

1.4

2.2

0.82

1.22

ug/l

1.22

253

Overjet

117

1.11

0.07

3.8

5.5

1.57

1.91

ug/l

0.21

117

Infections specific to the perinatal period

1.03

0.07

7.6

5.7

2.52

2.04

ug/l

—

Labour and delivery complicated by umbilical cord complications

0.87

0.07

1.1

2.1

1.09

0.83

ug/l

—

Polyhydramnios

0.84

0.07

1.0

1.9

0.72

1.52

ug/l

—

Alcohol-induced chronic pancreatitis

0.83

0.07

2.6

2.9

2.79

1.03

ug/l

—

Malignant neoplasm of head and neck

0.83

0.07

1.9

2.6

0.78

0.86

ug/l

—

Medical abortion

106

588

0.98

0.07

2.1

1.30

1.20

ug/l

0.19

101

570

Overexertion and strenuous or repetitive movements

157

1.08

0.07

1.8

2.5

0.67

1.09

ug/l

0.87

145

Other and unspecified local infections of skin and subcutaneous tissue

157

1.08

0.07

2.0

3.0

1.97

1.13

ug/l

0.63

148

Haemorrhagic and haematological disorders of fetus and newborn

150

1.08

0.07

6.0

5.7

3.75

2.02

ug/l

1.49

150

Foreign body in alimentary tract

1.02

0.07

2.7

3.1

1.23

1.67

ug/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.88

0.06

1.6

2.2

0.81

0.86

ug/l

—

Fall on and from ladder

1.11

0.06

2.4

2.5

0.68

1.05

ug/l

0.57

Malignant neoplasm of kidney, except renal pelvis

1.11

0.06

1.4

2.6

1.50

1.01

ug/l

0.15

Myocardial infarction, without ST-elevation

374

0.96

0.05

2.5

2.3

1.16

0.90

ug/l

0.41

355

Impacted cerumen

159

1.07

0.05

3.0

2.9

1.37

1.39

ug/l

0.02

151

Alzheimer’s disease (Late onset)

123

1.07

0.04

1.3

1.8

1.72

1.21

ug/l

0.35

114

Unspecified lump in breast

201

0.95

0.04

1.7

2.2

1.31

1.17

ug/l

0.11

192

Wet age-related macular degeneration

125

0.92

0.04

1.2

1.7

1.11

1.12

ug/l

0.01

115

Contact with other sharp object(s)

131

1.07

0.03

1.8

2.8

1.45

1.29

ug/l

0.11

121

Acute and subacute iridocyclitis

290

1.03

0.03

3.2

2.6

0.85

1.11

ug/l

0.53

272

Non-follicular lymphoma

102

1.08

0.03

2.2

2.0

1.37

1.20

ug/l

0.10

Puerperal sepsis

162

1.05

0.02

1.6

2.1

0.97

1.18

ug/l

0.42

156

Diabetic neuropathy

157

0.95

0.02

1.1

2.4

1.70

0.91

ug/l

0.48

144

Haemangioma and lymphangioma, any site

157

0.96

0.01

1.9

3.1

1.72

1.34

ug/l

0.16

148

Scissor bite

103

1.06

0.00

6.2

5.1

2.97

1.30

ug/l

0.93

103

Glucosamine medication

402

1.01

0.00

1.6

2.3

1.13

1.04

ug/l

0.17

386

Anterior Iridocyclitis

313

0.99

0.00

3.1

2.6

0.82

1.09

ug/l

0.56

294

Haemangioma, any site

141

0.99

0.00

2.0

2.8

0.85

1.42

ug/l

1.03

132

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

189

1.00

0.00

1.7

2.6

1.10

0.85

ug/l

0.47

176

Stenosis and insufficiency of lacrimal passages

108

1.02

0.00

2.2

2.6

0.75

1.20

ug/l

0.84

100

Allergic urticaria

158

1.01

0.00

2.8

3.2

1.62

1.42

ug/l

0.12

149

Malignant neoplasm of rectum, including Hilmo

116

1.03

0.00

3.9

2.5

0.78

0.90

ug/l

0.14

107

Bronchitis, not specified as acute or chronic

118

1.02

0.00

1.1

2.2

1.27

1.02

ug/l

0.15

108

Other obstructed labour

121

0.99

0.00

2.2

2.3

0.85

0.88

ug/l

0.03

114

Duodenal ulcer

1.01

0.00

1.6

2.4

3.50

0.81

ug/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

160

0.98

0.00

1.7

2.4

1.00

0.78

ug/l

0.42

148

LSIL lesion of the cervix uteri, vagina or vulva

242

0.99

0.00

2.3

2.2

1.53

1.12

ug/l

0.36

231

Seborrhoeic keratosis

301

1.00

0.00

2.1

2.5

1.46

0.90

ug/l

0.64

287

Senility

0.00

0.0

2.2

—

1.84

—

Idiopathic pulmonary fibrosis

0.92

0.00

1.8

1.87

1.25

ug/l

—

Acute gastritis

1.00

0.00

3.5

2.4

1.08

1.11

ug/l

—

Glaucoma secondary to eye trauma

0.00

0.0

2.6

—

1.85

—

Other specified/unspecified nutritional deficiencies

0.00

0.0

2.8

—

1.82

—

Other disorders of amino-acid metabolism

0.00

0.0

3.7

—

1.96

—

Blindness or visual impairment, binocular

0.00

0.0

3.8

—

1.10

—

Contact with other specified venomous animals

0.00

0.0

3.1

—

1.56

—

0.00

0.0

2.8

—

1.11

—

Generalized pustular psoriasis

0.00

0.0

3.5

—

1.63

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

0.0

3.3

—

3.94

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.0

2.1

—

1.42

—

Osteogenesis imperfecta

0.00

0.0

7.0

—

1.65

—

Car occupant injured in noncollision transport accident

0.86

0.00

1.4

2.5

0.60

1.15

ug/l

—

0.00

0.0

2.3

—

1.71

—

Unspecified misadventure during surgical and medical care

0.88

0.00

7.2

2.5

0.63

1.20

ug/l

—

Eccrine sweat disorders

0.00

0.0

4.0

—

2.01

—

Café au lait spots

0.00

0.0

4.9

—

4.33

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

3.3

—

1.95

—

Other inherited muscular atrophy

0.00

0.0

5.4

—

1.72

—

Hypersplenism

0.00

0.0

2.6

—

1.75

—

Tick-borne viral encephalitis

0.00

0.0

2.6

—

2.16

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

2.8

—

0.80

—

Use of peginterferon beta-1a

0.00

0.0

2.9

—

1.91

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.0

6.0

—

1.84

—

Other congenital malformations of respiratory system

0.00

0.0

4.8

—

4.15

—

ILD, hospital admissions 3, with pneumonia sepsis

0.96

-0.00

1.0

2.1

1.03

1.17

ug/l

—

Sequelae of transport accidents

0.00

-0.00

0.0

1.5

—

0.21

—

Other and unspecified medical devices associated with adverse incidents

0.00

-0.00

0.0

3.5

—

1.07

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

2.6

—

1.00

—

Fall involving playground equipment

1.02

-0.00

5.2

6.4

2.16

2.43

ug/l

—

Exposure to ignition of highly flammable material

0.00

-0.00

0.0

1.2

—

0.09

—

Exposure to excessive heat of man-made origin

0.00

-0.00

0.0

3.8

—

1.25

—

Respiratory tuberculosis, clinically confirmed

0.00

-0.00

0.0

2.9

—

0.95

—

Osteitis due to dental implant

0.00

-0.00

0.0

2.3

—

1.57

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

3.2

—

1.08

—

Right side

0.00

-0.00

0.0

2.8

—

0.62

—

Traction detachment of retina

0.00

-0.00

0.0

2.3

—

0.65

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

2.8

—

0.32

—

Effects of heat and light

0.00

-0.00

0.0

2.3

—

1.85

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.3

—

0.67

—

Crushing injury of ankle and foot

0.00

-0.00

0.0

2.4

—

1.39

—

Ascites

1.00

-0.00

1.6

2.9

1.21

1.23

ug/l

—

0.93

-0.00

4.8

5.0

1.67

1.64

ug/l

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

7.0

—

0.84

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

-0.00

0.0

7.7

—

1.30

—

Tic and related disorders

0.97

-0.00

5.0

5.3

2.11

1.93

ug/l

—

Single ventricle heart

0.00

-0.00

0.0

6.6

—

2.79

—

Abnormality of red blood cells

0.00

-0.00

0.0

4.3

—

0.33

—

Syndactyly

0.00

-0.00

0.0

5.8

—

0.86

—

Congenital malformations of nose, including avohilmo

0.00

-0.00

0.0

3.8

—

1.34

—

Fusion of the labia, including avohilmo

0.00

-0.00

0.0

5.8

—

1.57

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

4.4

—

4.68

—

Congenital glaucoma

0.00

-0.00

0.0

4.3

—

2.67

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

5.2

—

1.41

—

Congenital malformations of aortic and mitral valves

0.91

-0.00

5.1

4.4

3.29

1.50

ug/l

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

-0.00

0.0

5.2

—

0.87

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

3.0

—

5.25

—

Toxic effect of organic solvents

0.00

-0.00

0.0

1.6

—

0.45

—

Microtia (small ears)

0.00

-0.00

0.0

7.2

—

0.75

—

Cleft lip and palate

0.00

-0.00

0.0

6.0

—

1.25

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.98

-0.00

1.6

2.2

0.85

0.86

ug/l

—

Other congenital malformations of eye

0.00

-0.00

0.0

4.9

—

2.98

—

Acquired pure red cell aplasia [erythroblastopenia]

0.00

-0.00

0.0

3.8

—

1.85

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

5.0

—

1.11

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

5.2

—

2.98

—

Unspecified renal colic

0.00

-0.00

0.0

2.0

—

1.59

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.6

—

4.73

—

Migraine, unspecified, drug-induced

0.00

-0.00

0.0

2.8

—

1.57

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

2.7

—

2.80

—

Dermatopolymyositis, unspecified

0.00

-0.00

0.0

2.6

—

1.87

—

Hypertrophy of bone

0.00

-0.00

0.0

3.0

—

0.47

—

Endometriosis in cutaneous scar

0.00

-0.00

0.0

2.6

—

2.10

—

Other and unspecified hypertrophic disorders of skin

0.00

-0.00

0.0

2.4

—

1.38

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

3.5

—

2.54

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

2.7

—

4.49

—

Hair colour and hair shaft abnormalities

0.00

-0.00

0.0

2.4

—

1.58

—

Impacted maxillary molar

130

1.00

-0.00

2.5

2.4

1.23

1.12

ug/l

0.06

122

Other and unspecified parapsoriasis

0.00

-0.00

0.0

1.0

—

1.31

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.8

—

1.52

—

Enteropathogenic Escherichia coli infection

0.00

-0.00

0.0

2.8

—

2.21

—

ILD, hospital admission 2, with pulmonary infections

100

1.00

-0.00

1.7

2.8

1.21

1.11

ug/l

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.5

—

0.24

—

ILD medications: acetylcysteine

0.00

-0.00

0.0

3.8

—

2.30

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

-0.00

0.0

3.4

—

3.77

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

-0.00

0.0

2.0

—

1.50

—

Enteritis due to Yersinia enterocolitica

0.00

-0.00

0.0

2.7

—

1.17

—

Hypertension, Pulmonary Arterial

0.00

-0.00

0.0

5.6

—

3.47

—

Chylothorax

0.00

-0.00

0.0

5.1

—

1.85

—

Other/unspecified mastoiditis and related conditions

0.00

-0.00

0.0

2.6

—

1.87

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

5.4

—

0.83

—

Chorioretinal scars

0.00

-0.00

0.0

1.6

—

1.79

—

Polyp of middle ear

0.00

-0.00

0.0

5.7

—

1.18

—

Other specified and unspecified disorders of choroid

0.00

-0.00

0.0

2.2

—

2.90

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

4.0

—

1.36

—

Other and unspecified heterotropia

0.00

-0.00

0.0

5.0

—

4.36

—

Idiopathic peripheral autonomic neuropathy

0.00

-0.00

0.0

4.0

—

4.56

—

Food allergy

0.00

-0.00

0.0

4.0

—

2.94

—

Contact urticaria

0.00

-0.00

0.0

1.6

—

1.71

—

Pityriasis lichenoides et varioliformis acuta

0.00

-0.00

0.0

2.6

—

0.96

—

Profound mental retardation

0.00

-0.00

0.0

6.9

—

2.21

—

Other and unspecified neuropathies

0.00

-0.00

0.0

2.3

—

1.07

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

3.8

—

4.07

—

Carcinoma in situ of prostate

0.00

-0.00

0.0

1.2

—

0.26

—

Other benign neoplasm of uterus: Cervix uteri

0.00

-0.00

0.0

2.4

—

1.95

—

0.00

-0.00

0.0

2.3

—

1.39

—

Toxic colitis

0.00

-0.00

0.0

2.6

—

1.08

—

Meningitis, viral

0.00

-0.00

0.0

3.2

—

0.96

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

0.00

-0.00

0.0

2.1

—

1.38

—

Congenital retinoschisis

0.00

-0.00

0.0

4.6

—

0.71

—

Digeorge syndrome

0.00

-0.00

0.0

6.2

—

4.80

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

-0.00

0.0

2.0

—

1.31

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.2

—

0.22

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

0.93

-0.00

3.0

2.3

2.37

1.58

ug/l

—

Osteosarcoma, including Hilmo

0.00

-0.00

0.0

4.5

—

1.49

—

Qualitative platelet defects

0.00

-0.00

0.0

5.0

—

1.23

—

Rare circulating lymphoid malignancy

0.00

-0.00

0.0

4.3

—

4.09

—

Ependymoma

0.00

-0.00

0.0

6.3

—

1.73

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

5.2

—

1.41

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

2.3

—

0.91

—

Dissection of cerebral arteries, nonruptured

0.00

-0.00

0.0

2.4

—

1.27

—

Atlantoaxial subluxation

0.00

-0.00

0.0

2.6

—

1.23

—

Meretoja disease

0.00

-0.00

0.0

2.6

—

1.11

—

Shigellosis

0.00

-0.00

0.0

2.3

—

0.94

—

Acute hepatitis B

0.00

-0.00

0.0

3.0

—

0.81

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

2.6

—

1.07

—

Gilbert syndrome

0.00

-0.00

0.0

2.8

—

0.98

—

Labyrinthitis

0.00

-0.00

0.0

3.3

—

3.95

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

2.6

—

0.31

—

Disorders of male genital organs in diseases classified elsewhere

0.00

-0.00

0.0

1.3

—

0.20

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

3.2

—

1.51

—

Erysipeloid, including avohilmo

0.00

-0.00

0.0

1.3

—

1.79

—

Acute hepatitis B, including avohilmo

0.00

-0.00

0.0

3.0

—

0.81

—

Nonalcoholic steatohepatitis

0.00

-0.00

0.0

2.1

—

1.27

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

0.00

-0.00

0.0

2.7

—

0.33

—

Congenital retinoschisis

0.00

-0.00

0.0

4.2

—

0.60

—

Tick-borne viral encephalitis, including avohilmo

0.00

-0.00

0.0

2.6

—

2.16

—

Melanocytic naevi of lip

0.00

-0.00

0.0

2.6

—

1.39

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

4.0

—

1.92

—

Other dermatomyositis

0.00

-0.00

0.0

2.6

—

1.16

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Somatotropin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS